Activation	O
and	O
expression	O
of	O
the	O
nuclear	B-protein
factors	I-protein
of	O
activated	B-cell_type
T	I-cell_type
cells	I-cell_type
,	O
NFATp	B-protein
and	O
NFATc	B-protein
,	O
in	O
human	B-cell_type
natural	I-cell_type
killer	I-cell_type
cells	I-cell_type
:	O
regulation	O
upon	O
CD16	B-protein
ligand	O
binding	O
.	O

The	O
putative	O
factors	O
that	O
couple	O
the	O
signal	O
transduction	O
from	O
surface	O
receptors	O
to	O
the	O
activation	O
of	O
cytokine	B-protein
synthesis	O
in	O
natural	B-cell_type
killer	I-cell_type
(	I-cell_type
NK	I-cell_type
)	I-cell_type
cells	I-cell_type
have	O
not	O
been	O
elucidated	O
.	O

We	O
report	O
here	O
that	O
the	O
nuclear	B-protein
factor	I-protein
of	O
activated	B-cell_type
T	I-cell_type
cells	I-cell_type
(	O
NFATp	B-protein
)	O
,	O
a	O
cyclosporin	B-protein
A	I-protein
(	I-protein
CsA	I-protein
)	I-protein
-sensitive	I-protein
factor	I-protein
that	O
regulates	O
the	O
transcription	O
of	O
several	O
cytokines	B-protein
,	O
mediates	O
CD16	B-protein
-induced	O
activation	O
of	O
cytokine	B-protein
genes	I-protein
in	O
human	B-cell_type
NK	I-cell_type
cells	I-cell_type
.	O

CD16	B-protein
(	O
Fc	B-protein
gamma	I-protein
RIIIA	I-protein
)	O
-induced	O
expression	O
of	O
cytokine	B-RNA
mRNA	I-RNA
in	O
NK	B-cell_type
cells	I-cell_type
occurs	O
via	O
a	O
CsA-sensitive	O
and	O
Ca	O
(	O
2+	O
)	O
-dependent	O
mechanism	O
.	O

Stimulation	O
of	O
NK	B-cell_type
cells	I-cell_type
with	O
CD16	B-protein
ligands	O
induces	O
NFAT	B-protein
-like	O
DNA	O
binding	O
activity	O
in	O
the	O
nuclear	O
extracts	O
from	O
these	O
cells	O
,	O
as	O
detected	O
in	O
electrophoretic	O
mobility	O
shift	O
assays	O
.	O

This	O
occurs	O
with	O
fast	O
kinetics	O
after	O
stimulation	O
,	O
via	O
a	O
CsA-sensitive	O
and	O
Ca	O
(	O
2+	O
)	O
-dependent	O
mechanism	O
that	O
does	O
not	O
require	O
de	O
novo	O
protein	O
synthesis	O
.	O

NK	B-protein
cell	I-protein
NFAT	I-protein
is	O
present	O
in	O
the	O
cytosol	O
of	O
nonstimulated	B-cell_type
cells	I-cell_type
,	O
migrates	O
to	O
the	O
nucleus	O
upon	O
stimulation	O
,	O
and	O
can	O
associate	O
with	O
AP-1	B-protein
.	O

Two	O
distinct	O
molecules	O
,	O
NFATp	B-protein
and	O
NFATc	B-protein
,	O
have	O
been	O
reported	O
to	O
mediate	O
NFAT	B-protein
activity	O
.	O

The	O
results	O
of	O
supershift	O
assays	O
using	O
NFATp-	B-protein
and	I-protein
NFATc-	I-protein
specific	I-protein
antibodies	I-protein
indicate	O
that	O
NK	O
cell	O
activation	O
early	O
after	O
CD16	B-protein
ligand	O
binding	O
involves	O
primarily	O
,	O
if	O
not	O
exclusively	O
,	O
NFATp	B-protein
,	O
and	O
Western	O
blot	O
analysis	O
shows	O
that	O
this	O
has	O
the	O
same	O
electrophoretic	O
mobility	O
(	O
approximately	O
120	O
kD	O
)	O
as	O
that	O
of	O
T	B-cell_type
lymphocytes	I-cell_type
.	O

NK	B-cell_type
cells	I-cell_type
do	O
not	O
express	O
NFATc	B-protein
constitutively	O
,	O
but	O
NFATc	B-RNA
mRNA	I-RNA
accumulation	O
is	O
induced	O
in	O
these	O
cells	O
within	O
2	O
h	O
of	O
stimulation	O
with	O
CD16	O
ligands	O
.	O

However	O
,	O
supershift	O
assays	O
using	O
the	O
available	O
mAb	B-protein
recognizing	O
the	O
T	B-protein
cell	I-protein
NFATc	I-protein
revealed	O
no	O
detectable	O
NFATc	B-protein
protein	O
in	O
nuclear	O
and	O
cytoplasmic	O
extracts	O
from	O
CD16-	O
or	O
phorbol	B-cell_line
ester-stimulated	I-cell_line
cells	I-cell_line
at	O
any	O
time	O
tested	O
,	O
up	O
to	O
4	O
h	O
.	O

These	O
results	O
provide	O
the	O
first	O
direct	O
evidence	O
that	O
both	O
CsA-sensitive	B-protein
transcription	I-protein
factors	I-protein
,	O
NFATp	B-protein
and	O
NFATc	B-protein
,	O
are	O
expressed	O
in	O
human	O
NK	B-cell_type
cells	I-cell_type
,	O
and	O
that	O
their	O
activation	O
and/or	O
expression	O
can	O
be	O
regulated	O
in	O
primary	O
cells	O
by	O
a	O
single	O
stimulus	O
,	O
that	O
,	O
in	O
the	O
case	O
of	O
CD16	O
in	O
NK	B-cell_type
cells	I-cell_type
,	O
results	O
in	O
early	O
activation	O
of	O
NFATp	B-protein
and	O
subsequently	O
induced	O
expression	O
of	O
NFATc	B-RNA
mRNA	I-RNA
.	O

Activation	NULL
and	NULL
Expression	NULL
of	NULL
the	NULL
Nuclear	NULL
Factors	NULL
of	NULL
Activated	NULL
T	NULL
Cells	NULL
,	NULL
NFATp	NULL
and	NULL
NFATc	NULL
,	NULL
in	NULL
Human	NULL
Natural	NULL
Killer	NULL
Cells	NULL
:	NULL
Regulation	NULL
upon	NULL
CD16	NULL
Ligand	NULL
Binding	NULL
By	NULL
Jos√©	NULL
Aramburu	NULL
,	NULL
``	NULL
Livio	NULL
Azzoni	NULL
,	NULL
``	NULL
Anjana	NULL
Rao	NULL
,	NULL
?	NULL

and	NULL
Bice	NULL
Perussia*	NULL
From	NULL
the	NULL
*Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
Jefferson	NULL
Cancer	NULL
Institute	NULL
,	NULL
Thomas	NULL
Jefferson	NULL
University	NULL
,	NULL
Philadelphia	NULL
,	NULL
Pennsylvania	NULL
19107	NULL
;	NULL
and	NULL
tDivision	NULL
of	NULL
Cellular	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Dana	NULL
Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02115	NULL
Summary	NULL
The	NULL
putative	NULL
factors	NULL
that	NULL
couple	NULL
the	NULL
signal	NULL
transduction	NULL
from	NULL
surface	NULL
receptors	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
cytokine	NULL
synthesis	NULL
in	NULL
natural	NULL
killer	NULL
(	NULL
NK	NULL
)	NULL
cells	NULL
have	NULL
not	NULL
been	NULL
elucidated	NULL
.	NULL

We	NULL
report	NULL
here	NULL
that	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFATp	NULL
)	NULL
,	NULL
a	NULL
cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
-sensitive	NULL
factor	NULL
that	NULL
regulates	NULL
the	NULL
transcription	NULL
of	NULL
several	NULL
cytokines	NULL
,	NULL
mediates	NULL
CD16-induced	NULL
activation	NULL
of	NULL
cytokine	NULL
genes	NULL
in	NULL
human	NULL
NK	NULL
cells	NULL
.	NULL

CD16	NULL
(	NULL
FeyRIIIA	NULL
)	NULL
-induced	NULL
expression	NULL
of	NULL
cytokine	NULL
mRNA	NULL
in	NULL
NK	NULL
cells	NULL
occurs	NULL
via	NULL
a	NULL
CsA-sensitive	NULL
and	NULL
Ca*+-dependent	NULL
mechanism	NULL
.	NULL

Stimulation	NULL
of	NULL
NK	NULL
cells	NULL
with	NULL
CD16	NULL
ligands	NULL
induces	NULL
NFAT-like	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
the	NULL
nuclear	NULL
extracts	NULL
from	NULL
these	NULL
cells	NULL
,	NULL
as	NULL
detected	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

This	NULL
occurs	NULL
with	NULL
fast	NULL
kinetics	NULL
after	NULL
stimulation	NULL
,	NULL
via	NULL
a	NULL
CsA-sensitive	NULL
and	NULL
Ca**-dependent	NULL
mechanism	NULL
that	NULL
does	NULL
not	NULL
require	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
.	NULL

NK	NULL
cell	NULL
NFAT	NULL
is	NULL
present	NULL
in	NULL
the	NULL
cytosol	NULL
of	NULL
nonstimulated	NULL
cells	NULL
,	NULL
migrates	NULL
to	NULL
the	NULL
nucleus	NULL
upon	NULL
stimulation	NULL
,	NULL
and	NULL
can	NULL
associate	NULL
with	NULL
AP-1	NULL
.	NULL

Two	NULL
distinct	NULL
molecules	NULL
,	NULL
NFATp	NULL
and	NULL
NFATe	NULL
,	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
mediate	NULL
NFAT	NULL
activity	NULL
.	NULL

The	NULL
results	NULL
of	NULL
supershift	NULL
assays	NULL
using	NULL
NFATp-	NULL
and	NULL
NFATe-specific	NULL
antibodies	NULL
indicate	NULL
that	NULL
NK	NULL
cell	NULL
activation	NULL
early	NULL
after	NULL
CD16	NULL
ligand	NULL
binding	NULL
involves	NULL
primarily	NULL
,	NULL
if	NULL
not	NULL
exclusively	NULL
,	NULL
NFATp	NULL
,	NULL
and	NULL
Western	NULL
blot	NULL
analysis	NULL
shows	NULL
that	NULL
this	NULL
has	NULL
the	NULL
same	NULL
electrophoretic	NULL
mobility	NULL
(	NULL
~120	NULL
kD	NULL
)	NULL
as	NULL
that	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

NK	NULL
cells	NULL
do	NULL
not	NULL
express	NULL
NFAT	NULL
constitutively	NULL
,	NULL
but	NULL
NFATe	NULL
mRNA	NULL
accumulation	NULL
is	NULL
induced	NULL
in	NULL
these	NULL
cells	NULL
within	NULL
2	NULL
h	NULL
of	NULL
stimulation	NULL
with	NULL
CD16	NULL
ligands	NULL
.	NULL

However	NULL
,	NULL
supershift	NULL
assays	NULL
using	NULL
the	NULL
available	NULL
mAb	NULL
recognizing	NULL
the	NULL
T	NULL
cell	NULL
NFATe	NULL
revealed	NULL
no	NULL
detectable	NULL
NFAT	NULL
protein	NULL
in	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
extracts	NULL
from	NULL
CD16-	NULL
or	NULL
phorbol	NULL
ester-stimulated	NULL
cells	NULL
at	NULL
any	NULL
time	NULL
tested	NULL
,	NULL
up	NULL
to	NULL
4	NULL
h.	NULL
These	NULL
results	NULL
provide	NULL
the	NULL
first	NULL
direct	NULL
evidence	NULL
that	NULL
both	NULL
CsA-sensitive	NULL
transcription	NULL
factors	NULL
,	NULL
NFATp	NULL
and	NULL
NFATe	NULL
,	NULL
are	NULL
expressed	NULL
in	NULL
human	NULL
NK	NULL
cells	NULL
,	NULL
and	NULL
that	NULL
their	NULL
activation	NULL
and/or	NULL
expression	NULL
can	NULL
be	NULL
regulated	NULL
in	NULL
primary	NULL
cells	NULL
by	NULL
a	NULL
single	NULL
stimulus	NULL
that	NULL
,	NULL
in	NULL
the	NULL
case	NULL
of	NULL
CD16	NULL
in	NULL
NK	NULL
cells	NULL
,	NULL
results	NULL
in	NULL
early	NULL
activation	NULL
of	NULL
NFATp	NULL
and	NULL
subsequently	NULL
induced	NULL
expression	NULL
of	NULL
NFATe	NULL
mRNA	NULL
.	NULL

K	NULL
cells	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
early	NULL
phases	NULL
of	NULL
an	NULL
immune	NULL
response	NULL
,	NULL
mediating	NULL
cytotoxicity	NULL
against	NULL
numerous	NULL
target	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
previous	NULL
sensitization	NULL
,	NULL
and	NULL
producing	NULL
cytokines	NULL
(	NULL
IFN-y	NULL
,	NULL
TNF	NULL
,	NULL
GM-CSF	NULL
,	NULL
and	NULL
IL-3	NULL
)	NULL
.	NULL

Both	NULL
functions	NULL
are	NULL
triggered	NULL
or	NULL
enhanced	NULL
upon	NULL
stimulation	NULL
with	NULL
target	NULL
cells	NULL
,	NULL
immune	NULL
complexes	NULL
,	NULL
and	NULL
lymphokines	NULL
,	NULL
each	NULL
binding	NULL
to	NULL
different	NULL
receptors	NULL
(	NULL
reviewed	NULL
in	NULL
references	NULL
1-3	NULL
)	NULL
.	NULL

The	NULL
proximal	NULL
intracellular	NULL
events	NULL
induced	NULL
upon	NULL
ligand	NULL
binding	NULL
to	NULL
the	NULL
transmembrane	NULL
form	NULL
of	NULL
the	NULL
low	NULL
affinity	NULL
receptor	NULL
for	NULL
IgG	NULL
(	NULL
CD16	NULL
,	NULL
FcyRIIIA	NULL
)	NULL
!	NULL

on	NULL
NK	NULL
cells	NULL
are	NULL
being	NULL
elucidated	NULL
(	NULL
4-8	NULL
)	NULL
,	NULL
but	NULL
no	NULL
information	NULL
is	NULL
available	NULL
on	NULL
the	NULL
distal	NULL
events	NULL
1	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
Act	NULL
D	NULL
,	NULL
actinomycin	NULL
D	NULL
;	NULL
B2M	NULL
,	NULL
B2	NULL
microglobulin	NULL
;	NULL
[	NULL
Ca2+	NULL
]	NULL
;	NULL
,	NULL
intracellular	NULL
Ca	NULL
#	NULL
+	NULL
concentration	NULL
;	NULL
CsA	NULL
,	NULL
cyclosporin	NULL
A	NULL
;	NULL
E	NULL
,	NULL
erythrocytes	NULL
;	NULL
EA	NULL
,	NULL
Ab-coated	NULL
erythrocytes	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
FoyR	NULL
,	NULL
receptor	NULL
for	NULL
the	NULL
Fc	NULL
fragment	NULL
of	NULL
IgG	NULL
;	NULL
NFAT	NULL
,	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
;	NULL
NRS	NULL
,	NULL
nonimmune	NULL
rabbit	NULL
serum	NULL
;	NULL
PDBu	NULL
,	NULL
phorbol-12	NULL
,	NULL
13-dibutyrate	NULL
;	NULL
PKC	NULL
,	NULL
protein	NULL
kinase	NULL
C.	NULL
801	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

¬©	NULL
The	NULL
Rockefeller	NULL
University	NULL
Press	NULL
¬´	NULL
0022-1007/95/09/0801/10	NULL
$	NULL
2.00	NULL
Volume	NULL
182	NULL
September	NULL
1995	NULL
801-810	NULL
and/or	NULL
factors	NULL
involved	NULL
in	NULL
the	NULL
receptor-mediated	NULL
regulation	NULL
of	NULL
cytokine	NULL
genes	NULL
transcription	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

CD16-induced	NULL
production	NULL
of	NULL
cytokines	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
IFN-y	NULL
and	NULL
TNF	NULL
)	NULL
,	NULL
but	NULL
not	NULL
that	NULL
of	NULL
CD25	NULL
or	NULL
other	NULL
proteins	NULL
involved	NULL
in	NULL
cytotoxicity	NULL
(	NULL
8-10	NULL
)	NULL
,	NULL
depends	NULL
on	NULL
increased	NULL
intracellular	NULL
Ca	NULL
#	NULL
*	NULL
concentration	NULL
(	NULL
[	NULL
Ca**	NULL
)	NULL
;	NULL
)	NULL
after	NULL
extracellular	NULL
Ca	NULL
#	NULL
+	NULL
entrance	NULL
(	NULL
8	NULL
)	NULL
.	NULL

In	NULL
T	NULL
lymphocytes	NULL
,	NULL
the	NULL
TCR-induced	NULL
increase	NULL
of	NULL
[	NULL
Ca	NULL
#	NULL
*	NULL
]	NULL
;	NULL
is	NULL
also	NULL
a	NULL
requisite	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
several	NULL
lymphokines	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
11	NULL
)	NULL
,	NULL
and	NULL
a	NULL
pathway	NULL
has	NULL
been	NULL
elucidated	NULL
which	NULL
connects	NULL
the	NULL
[	NULL
Ca¬Æ*	NULL
]	NULL
;	NULL
increase	NULL
to	NULL
the	NULL
regulation	NULL
of	NULL
cytokine	NULL
transcription	NULL
via	NULL
activation	NULL
of	NULL
the	NULL
cytoplasmic	NULL
serine/threonine	NULL
phosphatase	NULL
calcineurin	NULL
A	NULL
and	NULL
its	NULL
subsequent	NULL
effect	NULL
on	NULL
the	NULL
transcription	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
(	NULL
11-15	NULL
)	NULL
.	NULL

NFAT	NULL
is	NULL
present	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
nonstimulated	NULL
cells	NULL
as	NULL
a	NULL
phosphoprotein	NULL
,	NULL
NFATp	NULL
,	NULL
which	NULL
,	NULL
dephosphorylated	NULL
upon	NULL
cellular	NULL
stimulation	NULL
,	NULL
migrates	NULL
into	NULL
the	NULL
nucleus	NULL
,	NULL
where	NULL
it	NULL
binds	NULL
specific	NULL
DNA	NULL
sequences	NULL
in	NULL
the	NULL
promoter/	NULL
enhancer	NULL
regions	NULL
of	NULL
cytokine	NULL
genes	NULL
(	NULL
reviewed	NULL
in	NULL
references	NULL
11	NULL
and	NULL
16-20	NULL
)	NULL
.	NULL

Originally	NULL
described	NULL
as	NULL
a	NULL
cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
-sensitive	NULL
factor	NULL
binding	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
21-23	NULL
)	NULL
,	NULL
NFAT	NULL
also	NULL
binds	NULL
NFAT-specific	NULL
sites	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
other	NULL
cytokines	NULL
(	NULL
IL-3	NULL
,	NULL
IL-4	NULL
,	NULL
TNF-a	NULL
,	NULL
and	NULL
GM-CSF	NULL
)	NULL
(	NULL
17	NULL
,	NULL
19	NULL
,	NULL
20	NULL
,	NULL
24	NULL
,	NULL
25	NULL
)	NULL
,	NULL
where	NULL
it	NULL
may	NULL
cooperate	NULL
with	NULL
other	NULL
factors	NULL
,	NULL
e.g	NULL
.	NULL

,	NULL
AP-1	NULL
(	NULL
IL-2	NULL
,	NULL
IL-3	NULL
,	NULL
and	NULL
GM-CSF	NULL
promoters	NULL
)	NULL
(	NULL
12	NULL
,	NULL
17	NULL
,	NULL
25	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
indicate	NULL
that	NULL
its	NULL
activity	NULL
is	NULL
not	NULL
restricted	NULL
to	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
.	NULL

The	NULL
distribution	NULL
of	NULL
NFAT	NULL
extends	NULL
beyond	NULL
Tx1	NULL
lympho-cytes	NULL
:	NULL
NFATp	NULL
is	NULL
transcriptionally	NULL
active	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
,	NULL
where	NULL
it	NULL
likely	NULL
regulates	NULL
expression	NULL
of	NULL
TNF	NULL
(	NULL
19	NULL
,	NULL
28	NULL
)	NULL
.	NULL

At	NULL
least	NULL
two	NULL
related	NULL
but	NULL
distinct	NULL
NFAT	NULL
proteins	NULL
exist	NULL
,	NULL
NFATp	NULL
and	NULL
NFAT	NULL
,	NULL
that	NULL
have	NULL
identical	NULL
binding	NULL
specificity	NULL
and	NULL
activation	NULL
requirements	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
,	NULL
and	NULL
they	NULL
are	NULL
expressed	NULL
in	NULL
several	NULL
hematopoietic	NULL
lineages	NULL
and	NULL
other	NULL
tissues	NULL
(	NULL
11	NULL
,	NULL
30	NULL
)	NULL
.	NULL

Unlike	NULL
NFATp	NULL
,	NULL
NFAT	NULL
is	NULL
not	NULL
constitutively	NULL
expressed	NULL
in	NULL
most	NULL
tissues	NULL
and	NULL
cell	NULL
lines	NULL
analyzed	NULL
,	NULL
but	NULL
is	NULL
inducible	NULL
in	NULL
lymphocytes	NULL
by	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
activators	NULL
and/or	NULL
agents	NULL
that	NULL
increase	NULL
[	NULL
Ca	NULL
#	NULL
*	NULL
]	NULL
;	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Its	NULL
distribution	NULL
in	NULL
hematopoietic	NULL
cell	NULL
subsets	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
physiological	NULL
stimuli	NULL
that	NULL
induce	NULL
its	NULL
expression	NULL
,	NULL
remain	NULL
to	NULL
be	NULL
elucidated	NULL
.	NULL

We	NULL
have	NULL
observed	NULL
that	NULL
CD16-induced	NULL
transcription	NULL
of	NULL
TNF	NULL
and	NULL
GM-CSF	NULL
mRNA	NULL
in	NULL
NK	NULL
cells	NULL
is	NULL
abrogated	NULL
by	NULL
CsA	NULL
.	NULL

This	NULL
data	NULL
,	NULL
coupled	NULL
with	NULL
the	NULL
reported	NULL
role	NULL
of	NULL
NFAT	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
several	NULL
cytokine	NULL
genes	NULL
,	NULL
led	NULL
us	NULL
to	NULL
analyze	NULL
its	NULL
expression	NULL
and	NULL
regulation	NULL
in	NULL
NK	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
presented	NULL
here	NULL
indicate	NULL
that	NULL
CD16	NULL
stimulation	NULL
in	NULL
human	NULL
NK	NULL
cells	NULL
sequentially	NULL
activates	NULL
NFATp	NULL
and	NULL
induces	NULL
NFATe	NULL
mRNA	NULL
accumulation	NULL
.	NULL

The	NULL
former	NULL
is	NULL
readily	NULL
activated	NULL
from	NULL
a	NULL
preformed	NULL
inactive	NULL
cytoplasmic	NULL
pool	NULL
,	NULL
whereas	NULL
the	NULL
latter	NULL
must	NULL
be	NULL
synthesized	NULL
de	NULL
novo	NULL
:	NULL
both	NULL
events	NULL
occur	NULL
in	NULL
a	NULL
CsA-sensitive	NULL
manner	NULL
and	NULL
require	NULL
extracellular	NULL
but	NULL
not	NULL
protein	NULL
synthesis	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
a	NULL
role	NULL
for	NULL
NFATp	NULL
and	NULL
,	NULL
possibly	NULL
,	NULL
NFATe	NULL
in	NULL
mediating	NULL
CD16-induced	NULL
expression	NULL
of	NULL
cytokine	NULL
genes	NULL
in	NULL
NK	NULL
cells	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cell	NULL
Preparations	NULL
and	NULL
Stimulation	NULL
.	NULL

'The	NULL
human	NULL
Jurkat	NULL
(	NULL
T	NULL
lym-phoblastoid	NULL
)	NULL
and	NULL
RPMI	NULL
8866	NULL
(	NULL
B	NULL
lymphoblastoid	NULL
)	NULL
,	NULL
the	NULL
monkey	NULL
802	NULL
NFAT	NULL
Activation	NULL
in	NULL
NK	NULL
Cells	NULL
kidney	NULL
COS-7	NULL
,	NULL
and	NULL
the	NULL
murine	NULL
mAb-producing	NULL
hybrid	NULL
B	NULL
cell	NULL
lines	NULL
were	NULL
maintained	NULL
in	NULL
culture	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
BioWhittaker	NULL
,	NULL
Walkersville	NULL
,	NULL
MD	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
and	NULL
100	NULL
ug/ml	NULL
glutamine	NULL
.	NULL

PBL	NULL
were	NULL
obtained	NULL
after	NULL
density	NULL
gradient	NULL
centrifuga-tion	NULL
of	NULL
venous	NULL
peripheral	NULL
blood	NULL
from	NULL
healthy	NULL
individuals	NULL
.	NULL

Homogeneous	NULL
NK	NULL
cell	NULL
preparations	NULL
(	NULL
>	NULL
98	NULL
%	NULL
CD16+/CD56+*/CD3~	NULL
and	NULL
<	NULL
1	NULL
%	NULL
CD3+	NULL
cells	NULL
by	NULL
indirect	NULL
immunofluorescence	NULL
and	NULL
flow	NULL
cytom-etry	NULL
)	NULL
were	NULL
purified	NULL
from	NULL
10-d	NULL
cocultures	NULL
of	NULL
PBL	NULL
with	NULL
30	NULL
Gy	NULL
irradiated	NULL
RPMI	NULL
8866	NULL
B	NULL
lymphoblastoid	NULL
cells	NULL
,	NULL
as	NULL
described	NULL
(	NULL
31	NULL
)	NULL
.	NULL

PHA	NULL
blasts	NULL
were	NULL
obtained	NULL
after	NULL
5	NULL
d	NULL
culture	NULL
of	NULL
PBL	NULL
(	NULL
5	NULL
x	NULL
10¬∞	NULL
cells	NULL
per	NULL
ml	NULL
culture	NULL
medium	NULL
)	NULL
with	NULL
0.5	NULL
ug/ml	NULL
PHA	NULL
(	NULL
PHA-M	NULL
;	NULL
Wellcome	NULL
Diagnostics	NULL
,	NULL
Dartford	NULL
,	NULL
England	NULL
)	NULL
.	NULL

NK	NULL
cells	NULL
(	NULL
5	NULL
x	NULL
105/ml	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
with	NULL
anti-CD16	NULL
mAb	NULL
or	NULL
CD16	NULL
ligands	NULL
.	NULL

The	NULL
murine	NULL
mAb	NULL
used	NULL
were	NULL
3G8	NULL
(	NULL
IgG1	NULL
,	NULL
anti-CD16	NULL
)	NULL
and	NULL
B159.5	NULL
(	NULL
IgG1	NULL
,	NULL
anti-CD56	NULL
)	NULL
(	NULL
as-citic	NULL
fluid	NULL
,	NULL
final	NULL
dilution	NULL
plus	NULL
10	NULL
ug/ml	NULL
goat	NULL
anti-mouse	NULL
Ig	NULL
as	NULL
a	NULL
cross-linking	NULL
reagent	NULL
.	NULL

Immune	NULL
complexes	NULL
(	NULL
rabbit	NULL
IgG-sensi-tized	NULL
bovine	NULL
erythrocytes	NULL
,	NULL
EA	NULL
)	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
10	NULL
)	NULL
;	NULL
non-sensitized	NULL
bovine	NULL
E	NULL
were	NULL
used	NULL
as	NULL
controls	NULL
.	NULL

Phorbol-12	NULL
,	NULL
13-dibutyrate	NULL
(	NULL
PDBu	NULL
;	NULL
Chemsyn	NULL
Science	NULL
Laboratories	NULL
,	NULL
Lenexa	NULL
,	NULL
KS	NULL
)	NULL
and	NULL
ionomycin	NULL
(	NULL
Sigma	NULL
)	NULL
were	NULL
used	NULL
at	NULL
a	NULL
10-7	NULL
M	NULL
and	NULL
0.1	NULL
ug/ml	NULL
final	NULL
concentra-tion	NULL
,	NULL
respectively	NULL
.	NULL

CsA	NULL
(	NULL
gift	NULL
from	NULL
Sandoz	NULL
Pharmaceutics	NULL
Inc.	NULL
,	NULL
Vienna	NULL
,	NULL
Austria	NULL
)	NULL
,	NULL
was	NULL
used	NULL
at	NULL
100	NULL
ng/ml	NULL
final	NULL
concentration	NULL
.	NULL

In	NULL
the	NULL
experiments	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
Ca	NULL
#	NULL
*	NULL
chelator	NULL
EGTA	NULL
(	NULL
1	NULL
mM	NULL
;	NULL
Sigma	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
MgCl	NULL
;	NULL
was	NULL
added	NULL
.	NULL

Inhibitors	NULL
of	NULL
RNA	NULL
(	NULL
actinomycin	NULL
D	NULL
[	NULL
Act	NULL
DJ	NULL
;	NULL
Calbiochem	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
protein	NULL
synthesis	NULL
(	NULL
emetine	NULL
;	NULL
Sigma	NULL
)	NULL
were	NULL
used	NULL
at	NULL
a	NULL
final	NULL
concentrations	NULL
of	NULL
10	NULL
ug/ml	NULL
and	NULL
15	NULL
uM	NULL
,	NULL
respectively	NULL
.	NULL

Cells	NULL
were	NULL
preincubated	NULL
with	NULL
the	NULL
inhibitors	NULL
for	NULL
30	NULL
min	NULL
,	NULL
and	NULL
stimulation	NULL
was	NULL
performed	NULL
in	NULL
their	NULL
presence	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

Northern	NULL
Blot	NULL
Analysis	NULL
.	NULL

-	NULL
Total	NULL
cellular	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
control	NULL
and	NULL
stimulated	NULL
cells	NULL
per	NULL
sample	NULL
)	NULL
using	NULL
RNAzol	NULL
(	NULL
Bio-tex	NULL
Laboratories	NULL
,	NULL
Houston	NULL
,	NULL
TX	NULL
)	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
cDNA	NULL
probes	NULL
specific	NULL
for	NULL
human	NULL
TNF	NULL
,	NULL
GM-CSF	NULL
,	NULL
and	NULL
32	NULL
microglobulin	NULL
(	NULL
32M	NULL
)	NULL
,	NULL
as	NULL
described	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

Full-length	NULL
NFATe	NULL
cDNA	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
G.	NULL
Crabtree	NULL
(	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
Stanford	NULL
University	NULL
,	NULL
Stanford	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
a	NULL
2.2-kb	NULL
Eco-RI	NULL
fragment	NULL
(	NULL
nucleotides	NULL
+1	NULL
to	NULL
+2,198	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

Integrity	NULL
and	NULL
amount	NULL
of	NULL
RNA	NULL
loaded	NULL
per	NULL
lane	NULL
were	NULL
visualized	NULL
on	NULL
ethidium	NULL
bromide-stained	NULL
gels	NULL
,	NULL
and	NULL
B2M	NULL
expression	NULL
was	NULL
used	NULL
for	NULL
normal-ization	NULL
.	NULL

cDNA	NULL
probes	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
a*P	NULL
]	NULL
dCTP	NULL
(	NULL
specific	NULL
activity	NULL
=	NULL
3,000	NULL
Ci/mmol	NULL
;	NULL
NEN	NULL
,	NULL
DuPont	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
by	NULL
random	NULL
hexamer	NULL
priming	NULL
(	NULL
Random	NULL
primer	NULL
kit	NULL
;	NULL
Amersham	NULL
Corp.	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

Hybridized	NULL
bands	NULL
were	NULL
visualized	NULL
on	NULL
the	NULL
blots	NULL
exposed	NULL
to	NULL
X-AR	NULL
films	NULL
(	NULL
Eastman	NULL
Kodak	NULL
,	NULL
Rochester	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Nuclear	NULL
Extracts	NULL
and	NULL
Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assays	NULL
(	NULL
EMSA	NULL
)	NULL
,	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
control	NULL
and	NULL
stimulated	NULL
cells	NULL
as	NULL
described	NULL
by	NULL
McCaffrey	NULL
et	NULL
al	NULL
.	NULL

(	NULL
32	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
(	NULL
20	NULL
x	NULL
10¬∞	NULL
)	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
PBS	NULL
and	NULL
resuspended	NULL
in	NULL
400	NULL
pl	NULL
ice-cold	NULL
lysis	NULL
buffer	NULL
(	NULL
Dignam	NULL
buffer	NULL
A	NULL
[	NULL
33	NULL
]	NULL
:	NULL
10	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
10	NULL
mM	NULL
NaCl	NULL
,	NULL
3	NULL
mM	NULL
MgC	NULL
)	NULL
]	NULL
;	NULL
,	NULL
0.1	NULL
mM	NULL
EGTA	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
1	NULL
mM	NULL
PMSF	NULL
,	NULL
2	NULL
ug/ml	NULL
each	NULL
leupeptin	NULL
and	NULL
aprotinin	NULL
)	NULL
.	NULL

After	NULL
10	NULL
min	NULL
on	NULL
ice	NULL
,	NULL
25	NULL
ul	NULL
of	NULL
10	NULL
%	NULL
NP-40	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
vortexed	NULL
and	NULL
centrifuged	NULL
(	NULL
4¬∞C	NULL
,	NULL
30	NULL
s	NULL
,	NULL
9,000	NULL
rpm	NULL
)	NULL
.	NULL

Pelleted	NULL
nuclei	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
buffer	NULL
A	NULL
and	NULL
lysed	NULL
in	NULL
50	NULL
ul	NULL
Dignam	NULL
high	NULL
salt	NULL
buffer	NULL
C	NULL
(	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
420	NULL
mM	NULL
NaCl	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
)	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
0.5	NULL
mM	NULL
PMSF	NULL
,	NULL
2	NULL
ug/ml	NULL
each	NULL
leupeptin	NULL
and	NULL
aprotinin	NULL
)	NULL
(	NULL
15	NULL
min	NULL
,	NULL
4¬∞C	NULL
)	NULL
.	NULL

After	NULL
lysis	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
centrifuged	NULL
(	NULL
12,000	NULL
rpm	NULL
,	NULL
10	NULL
min	NULL
,	NULL
4¬∞C	NULL
)	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
superna-tants	NULL
were	NULL
diluted	NULL
(	NULL
1:1	NULL
,	NULL
vol	NULL
:	NULL
vol	NULL
)	NULL
with	NULL
Dignam	NULL
buffer	NULL
D	NULL
(	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
100	NULL
mM	NULL
KCI	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
0.5	NULL
mM	NULL
PMSF	NULL
,	NULL
2	NULL
ug/ml	NULL
each	NULL
leupeptin	NULL
and	NULL
aprotinin	NULL
)	NULL
.	NULL

Protein	NULL
concentration	NULL
was	NULL
determined	NULL
using	NULL
the	NULL
Bradford	NULL
colori-	NULL
metric	NULL
method	NULL
(	NULL
Bio	NULL
Rad	NULL
Laboratories	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
extracts	NULL
were	NULL
used	NULL
immediately	NULL
or	NULL
after	NULL
storage	NULL
at	NULL
-80¬∞C	NULL
.	NULL

Hypotonic	NULL
extracts	NULL
enriched	NULL
in	NULL
cytoplasmic	NULL
proteins	NULL
were	NULL
prepared	NULL
according	NULL
to	NULL
Jain	NULL
et	NULL
al	NULL
.	NULL

(	NULL
34	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
(	NULL
2	NULL
x	NULL
10	NULL
``	NULL
)	NULL
were	NULL
incubated	NULL
(	NULL
10	NULL
min	NULL
on	NULL
ice	NULL
)	NULL
in	NULL
200	NULL
pl	NULL
of	NULL
7.5	NULL
mM	NULL
Tris	NULL
buffer	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
containing	NULL
1	NULL
mM	NULL
MgC	NULL
]	NULL
;	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
2	NULL
mM	NULL
PMSF	NULL
,	NULL
20	NULL
ug/ml	NULL
each	NULL
leupeptin	NULL
and	NULL
aprotinin	NULL
.	NULL

They	NULL
were	NULL
then	NULL
subjected	NULL
to	NULL
one	NULL
freeze/thaw	NULL
cycle	NULL
(	NULL
dry	NULL
ice-cooled	NULL
with	NULL
75	NULL
%	NULL
ethanol	NULL
)	NULL
,	NULL
centrifuged	NULL
(	NULL
12,000	NULL
rpm	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4¬∞C	NULL
)	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
-80¬∞C	NULL
until	NULL
use	NULL
.	NULL

EMSA	NULL
reactions	NULL
were	NULL
performed	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
a	NULL
final	NULL
25-ul	NULL
vol	NULL
.	NULL

Nuclear	NULL
and	NULL
,	NULL
when	NULL
indicated	NULL
,	NULL
cytoplasmic	NULL
hypotonic	NULL
extracts	NULL
(	NULL
3-7	NULL
and	NULL
7-10	NULL
ug	NULL
per	NULL
reaction	NULL
volume	NULL
,	NULL
respectively	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
with	NULL
1	NULL
ug	NULL
polyionisine	NULL
:	NULL
polycitidilic	NULL
acid	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
Biochemicals	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
in	NULL
binding	NULL
buffer	NULL
(	NULL
final	NULL
concentrations	NULL
=	NULL
8	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
84	NULL
mM	NULL
NaCl	NULL
,	NULL
20	NULL
mM	NULL
KCl	NULL
,	NULL
0.3	NULL
mM	NULL
MgCl	NULL
;	NULL
,	NULL
9	NULL
%	NULL
glycerol	NULL
,	NULL
0.04	NULL
mM	NULL
EDTA	NULL
,	NULL
0.2	NULL
mM	NULL
DTT	NULL
,	NULL
0.2	NULL
mM	NULL
PMSF	NULL
,	NULL
0.5	NULL
ug/ml	NULL
each	NULL
leupeptin	NULL
and	NULL
aprotinin	NULL
)	NULL
.	NULL

After	NULL
adding	NULL
0.5	NULL
ng	NULL
P-labeled	NULL
probes	NULL
,	NULL
the	NULL
reaction	NULL
was	NULL
continued	NULL
for	NULL
15	NULL
min	NULL
,	NULL
stopped	NULL
with	NULL
2	NULL
ul	NULL
0.1	NULL
%	NULL
(	NULL
wt/vol	NULL
)	NULL
bromophenol	NULL
blue	NULL
,	NULL
and	NULL
the	NULL
samples	NULL
were	NULL
electrophoresed	NULL
on	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
in	NULL
0.25	NULL
%	NULL
Tris-buffered	NULL
EDTA	NULL
under	NULL
nondenaturing	NULL
conditions	NULL
.	NULL

Cold	NULL
probes	NULL
used	NULL
as	NULL
competitors	NULL
were	NULL
added	NULL
at	NULL
the	NULL
beginning	NULL
of	NULL
the	NULL
reaction	NULL
to	NULL
identical	NULL
aliquots	NULL
of	NULL
the	NULL
extracts	NULL
.	NULL

The	NULL
Ab	NULL
used	NULL
for	NULL
supershift	NULL
(	NULL
antisera	NULL
,	NULL
or	NULL
ascites	NULL
from	NULL
mAb	NULL
,	NULL
1:250	NULL
final	NULL
concentration	NULL
)	NULL
were	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
20	NULL
min	NULL
with	NULL
the	NULL
nuclear	NULL
extracts	NULL
,	NULL
labeled	NULL
probes	NULL
were	NULL
added	NULL
,	NULL
and	NULL
the	NULL
reaction	NULL
continued	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
tem-perature	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
cognate	NULL
and	NULL
control	NULL
peptides	NULL
(	NULL
0.1	NULL
ug	NULL
)	NULL
were	NULL
preincubated	NULL
for	NULL
30	NULL
min	NULL
on	NULL
ice	NULL
with	NULL
the	NULL
Ab	NULL
in	NULL
the	NULL
reaction	NULL
mixture	NULL
without	NULL
nuclear	NULL
extracts	NULL
.	NULL

Extracts	NULL
were	NULL
then	NULL
added	NULL
and	NULL
incubated	NULL
for	NULL
20	NULL
min	NULL
on	NULL
ice	NULL
before	NULL
adding	NULL
the	NULL
labeled	NULL
probe	NULL
.	NULL

The	NULL
anti-	NULL
NFATp	NULL
antisera	NULL
72	NULL
and	NULL
67.1	NULL
and	NULL
their	NULL
cognate	NULL
and	NULL
control	NULL
peptides	NULL
have	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
29	NULL
,	NULL
35	NULL
)	NULL
,	NULL
and	NULL
the	NULL
anti-NFATe	NULL
mAb	NULL
7A6	NULL
(	NULL
30	NULL
)	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
G.	NULL
Crabtree	NULL
(	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
Stanford	NULL
University	NULL
)	NULL
.	NULL

The	NULL
Ab	NULL
used	NULL
recognize	NULL
both	NULL
human	NULL
and	NULL
murine	NULL
NFAT	NULL
.	NULL

Double-stranded	NULL
synthetic	NULL
oligonucleotide	NULL
DNA	NULL
probes	NULL
were	NULL
synthesized	NULL
in	NULL
the	NULL
Nucleic	NULL
Acid	NULL
Facility	NULL
at	NULL
the	NULL
Jefferson	NULL
Cancer	NULL
Institute	NULL
(	NULL
except	NULL
for	NULL
the	NULL
SP1	NULL
and	NULL
AP-1	NULL
probes	NULL
,	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
Inc.	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
were	NULL
end-labeled	NULL
with	NULL
[	NULL
y*P	NULL
]	NULL
ATP	NULL
(	NULL
specific	NULL
activity	NULL
=	NULL
4,500	NULL
Ci/mmol	NULL
;	NULL
ICN	NULL
Bio-medicals	NULL
Inc.	NULL
,	NULL
Costa	NULL
Mesa	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
Promega	NULL
Biotech	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
specifications	NULL
.	NULL

After	NULL
labeling	NULL
,	NULL
free	NULL
[	NULL
y*P	NULL
]	NULL
JATP	NULL
was	NULL
removed	NULL
by	NULL
cen-trifugation	NULL
on	NULL
Microspin	NULL
Sephacryl	NULL
$	NULL
-200	NULL
HR	NULL
columns	NULL
(	NULL
Pharmacia	NULL
Fine	NULL
Chemicals	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
oligonucleotide	NULL
probes	NULL
used	NULL
(	NULL
5	NULL
'	NULL
to	NULL
3	NULL
'	NULL
,	NULL
one	NULL
strand	NULL
)	NULL
are	NULL
:	NULL
human	NULL
IL-2	NULL
distal	NULL
NFAT	NULL
site	NULL
(	NULL
NFAT	NULL
hull-2	NULL
)	NULL
(	NULL
34	NULL
)	NULL
,	NULL
GGAGGAAAAACTGTTTCATACAGA-AGG	NULL
;	NULL
mouse	NULL
IL-4	NULL
NFAT	NULL
site	NULL
(	NULL
NFAT	NULL
mIl-4	NULL
)	NULL
(	NULL
20	NULL
,	NULL
24	NULL
)	NULL
,	NULL
ATAAAA-TTTTCCAATGTAAA	NULL
;	NULL
consensus	NULL
AP-	NULL
site	NULL
(	NULL
AP-	NULL
)	NULL
,	NULL
CGCTTGATG-ACTCAGCCGGAA	NULL
;	NULL
consensus	NULL
SP1	NULL
site	NULL
(	NULL
SP1	NULL
)	NULL
,	NULL
ATTCGATCGGTT	NULL
CGGGGCGAG	NULL
;	NULL
human	NULL
GM-CSF	NULL
(	NULL
GM-550	NULL
,	NULL
containing	NULL
an	NULL
NFAT	NULL
binding	NULL
site	NULL
)	NULL
(	NULL
17	NULL
)	NULL
,	NULL
TCTTATTATGACTCTTGCITTTCCTCCT	NULL
TTC	NULL
;	NULL
human	NULL
TNF	NULL
(	NULL
NF-	NULL
¬´	NULL
3	NULL
,	NULL
containing	NULL
an	NULL
NFAT-binding	NULL
site	NULL
)	NULL
:	NULL
CAGATGAGCTCATGGGTTTCTCCACC	NULL
(	NULL
19	NULL
)	NULL
(	NULL
used	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
)	NULL
,	NULL
and	NULL
GAGCTCATGGGTTTCTCCACC	NULL
(	NULL
36	NULL
)	NULL
(	NULL
used	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
C	NULL
)	NULL
.	NULL

The	NULL
NFAT	NULL
binding	NULL
sequences	NULL
in	NULL
the	NULL
relevant	NULL
probes	NULL
are	NULL
underlined	NULL
.	NULL

SDS-PAGE	NULL
and	NULL
Western	NULL
Blot	NULL
Analysis	NULL
:	NULL
Cells	NULL
(	NULL
5	NULL
x	NULL
106	NULL
)	NULL
were	NULL
resuspended	NULL
in	NULL
30	NULL
pl	NULL
lysis	NULL
buffer	NULL
(	NULL
40	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
10	NULL
mM	NULL
EDTA	NULL
,	NULL
60	NULL
mM	NULL
NaPO	NULL
,	NULL
)	NULL
plus	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
10	NULL
%	NULL
SDS	NULL
.	NULL

Lysates	NULL
were	NULL
boiled	NULL
for	NULL
20	NULL
min	NULL
.	NULL

SDS-PAGE	NULL
(	NULL
7.5	NULL
%	NULL
acrylamide	NULL
,	NULL
reducing	NULL
conditions	NULL
)	NULL
,	NULL
Western	NULL
blot	NULL
,	NULL
and	NULL
enhanced	NULL
chemiluminescence	NULL
detection	NULL
(	NULL
Amersham	NULL
)	NULL
were	NULL
done	NULL
according	NULL
to	NULL
standard	NULL
procedures	NULL
(	NULL
7	NULL
)	NULL
.	NULL

803	NULL
Aramburu	NULL
et	NULL
al	NULL
.	NULL

ass	NULL
B2M	NULL
e	NULL
e	NULL
e	NULL
e	NULL
¬Æ	NULL
¬Æ	NULL
188	NULL
Figure	NULL
1	NULL
.	NULL

Effect	NULL
of	NULL
CsA	NULL
,	NULL
chelation	NULL
,	NULL
and	NULL
RNA	NULL
and	NULL
protein	NULL
synthesis	NULL
inhibition	NULL
on	NULL
CD16-induced	NULL
accumulation	NULL
of	NULL
TNF	NULL
and	NULL
GM-CSF	NULL
mRNA	NULL
.	NULL

NK	NULL
cells	NULL
(	NULL
30	NULL
x	NULL
106	NULL
per	NULL
sample	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
in	NULL
(	NULL
A	NULL
)	NULL
medium	NULL
without	NULL
(	NULL
-	NULL
)	NULL
or	NULL
with	NULL
(	NULL
+	NULL
)	NULL
100	NULL
ng/ml	NULL
CsA	NULL
,	NULL
or	NULL
1	NULL
mM	NULL
EGTA	NULL
,	NULL
(	NULL
B	NULL
)	NULL
mediam	NULL
without	NULL
(	NULL
None	NULL
)	NULL
or	NULL
with	NULL
CsA	NULL
,	NULL
10	NULL
ug/ml	NULL
Act	NULL
D	NULL
,	NULL
15	NULL
uM	NULL
emetine	NULL
,	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
CsA	NULL
and	NULL
emetine	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Medium	NULL
(	NULL
B	NULL
,	NULL
-	NULL
)	NULL
,	NULL
E	NULL
,	NULL
or	NULL
EA	NULL
(	NULL
0.5	NULL
%	NULL
suspension	NULL
final	NULL
concentration	NULL
)	NULL
was	NULL
added	NULL
to	NULL
each	NULL
of	NULL
three	NULL
identical	NULL
aliquots	NULL
from	NULL
the	NULL
same	NULL
samples	NULL
and	NULL
the	NULL
incubation	NULL
was	NULL
continued	NULL
for	NULL
2	NULL
h.	NULL
Cells	NULL
were	NULL
washed	NULL
and	NULL
total	NULL
RNA	NULL
was	NULL
extracted	NULL
and	NULL
size	NULL
fraction-ated	NULL
in	NULL
a	NULL
1	NULL
%	NULL
agarose	NULL
denaturing	NULL
gel	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
TNF	NULL
and	NULL
GM-CSF	NULL
(	NULL
fop	NULL
)	NULL
or	NULL
B2M	NULL
(	NULL
A	NULL
,	NULL
bottom	NULL
)	NULL
random	NULL
primer-labeled	NULL
cDNA	NULL
probes	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Ethiduim	NULL
bromide	NULL
staining	NULL
of	NULL
the	NULL
corresponding	NULL
gel	NULL
is	NULL
shown	NULL
in	NULL
R	NULL
Results	NULL
CsA	NULL
Sensitivity	NULL
of	NULL
CD16-induced	NULL
Cytokine	NULL
mRNA	NULL
Agcumu-lation	NULL
.	NULL

_	NULL
TNF	NULL
and	NULL
GM-CSF	NULL
mRNA	NULL
are	NULL
induced	NULL
to	NULL
accumulate	NULL
in	NULL
NK	NULL
cells	NULL
stimulated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
immune	NULL
complexes	NULL
(	NULL
EA	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
)	NULL
or	NULL
anti-CD16	NULL
mAb	NULL
(	NULL
reference	NULL
9	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
effect	NULL
is	NULL
abolished	NULL
upon	NULL
chelation	NULL
of	NULL
ex	NULL
NFAT	NULL
Figure	NULL
2	NULL
.	NULL

NFAT	NULL
activation	NULL
in	NULL
NK	NULL
cells	NULL
upon	NULL
CD16	NULL
stimulation	NULL
.	NULL

(	NULL
4	NULL
)	NULL
NK	NULL
cells	NULL
(	NULL
5	NULL
x	NULL
106/ml	NULL
,	NULL
10	NULL
``	NULL
per	NULL
sample	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
in	NULL
medium	NULL
without	NULL
(	NULL
None	NULL
)	NULL
or	NULL
with	NULL
ascites	NULL
(	NULL
10-3	NULL
final	NULL
dilution	NULL
)	NULL
of	NULL
mAb	NULL
B159.5	NULL
(	NULL
CD56	NULL
,	NULL
control	NULL
)	NULL
or	NULL
3G8	NULL
(	NULL
CD16	NULL
)	NULL
,	NULL
each	NULL
with	NULL
added	NULL
10	NULL
ug/ml	NULL
goat	NULL
anti-mouse	NULL
as	NULL
cross-linker	NULL
;	NULL
E	NULL
or	NULL
EA	NULL
(	NULL
each	NULL
0.5	NULL
%	NULL
suspension	NULL
final	NULL
concen-tration	NULL
)	NULL
;	NULL
or	NULL
10-7	NULL
M	NULL
PDBu	NULL
plus	NULL
0.1	NULL
ug/ml	NULL
ionomycin	NULL
(	NULL
P/T	NULL
)	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Cells	NULL
were	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
in	NULL
medium	NULL
without	NULL
(	NULL
-	NULL
)	NULL
or	NULL
with	NULL
(	NULL
+	NULL
)	NULL
CsA	NULL
or	NULL
EGTA	NULL
,	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Medium	NULL
(	NULL
None	NULL
)	NULL
,	NULL
E	NULL
,	NULL
or	NULL
EA	NULL
were	NULL
then	NULL
added	NULL
to	NULL
each	NULL
of	NULL
107	NULL
cell	NULL
aliquots	NULL
and	NULL
the	NULL
incubation	NULL
was	NULL
continued	NULL
for	NULL
1	NULL
h.	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
NFAT	NULL
activation	NULL
was	NULL
assessed	NULL
by	NULL
EMSA	NULL
(	NULL
3	NULL
ug	NULL
protein	NULL
per	NULL
lane	NULL
)	NULL
in	NULL
5	NULL
%	NULL
acrylamide	NULL
nondenaturing	NULL
gels	NULL
using	NULL
a	NULL
*	NULL
?	NULL

P-labeled	NULL
dsDNA	NULL
oligonucleotide	NULL
probe	NULL
corresponding	NULL
to	NULL
the	NULL
distal	NULL
NFAT	NULL
site	NULL
of	NULL
the	NULL
human	NULL
II-2	NULL
promotor	NULL
(	NULL
NFAT	NULL
hull	NULL
>	NULL
2	NULL
)	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Cold	NULL
competitor	NULL
(	NULL
fold	NULL
molar	NULL
)	NULL
Cold	NULL
competitor	NULL
NFAT	NULL
-	NULL
GM-550	NULL
-	NULL
NF-3	NULL
SP1	NULL
i	NULL
2	NULL
None	NULL
¬´	NULL
--	NULL
-	NULL
2s	NULL
100	NULL
25	NULL
100	NULL
25	NULL
100	NULL
25	NULL
100	NULL
None	NULL
NFAT	NULL
AP-	NULL
SP1	NULL
IL-2	NULL
IL-4	NULL
FAT	NULL
_	NULL
A	NULL
neat	NULL
-	NULL
(	NULL
#	NULL
NFAT	NULL
Fp	NULL
Lu	NULL
ll	NULL
M	NULL
‚Äú	NULL
I	NULL
HM	NULL
C	NULL
Stimulus	NULL
:	NULL
None	NULL
E	NULL
EA	NULL
a	NULL
NF	NULL
NFAT	NULL
SPI	NULL
P	NULL
2	NULL
K3	NULL
1L2L4	NULL
NFAT	NULL
co	NULL
Nols	NULL
Whois	NULL
Hh	NULL
tth	NULL
dttcs	NULL
Figure	NULL
3	NULL
.	NULL

DNA	NULL
binding	NULL
specificity	NULL
of	NULL
NK	NULL
cells	NULL
NFAT	NULL
.	NULL

In	NULL
A	NULL
and	NULL
B	NULL
,	NULL
identical	NULL
aliquots	NULL
of	NULL
nuclear	NULL
extracts	NULL
(	NULL
5	NULL
ug	NULL
proteins	NULL
per	NULL
lane	NULL
)	NULL
from	NULL
NK	NULL
cells	NULL
stimulated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
EA	NULL
were	NULL
incubated	NULL
without	NULL
(	NULL
None	NULL
)	NULL
,	NULL
with	NULL
25-	NULL
and	NULL
100-fold	NULL
(	NULL
A	NULL
)	NULL
,	NULL
or	NULL
80-fold	NULL
molar	NULL
excess	NULL
(	NULL
B	NULL
)	NULL
of	NULL
the	NULL
indicated	NULL
cold	NULL
dsDNA	NULL
oligonucleotides	NULL
before	NULL
adding	NULL
the	NULL
labeled	NULL
NFAT	NULL
hull-2	NULL
probe	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Identical	NULL
aliquots	NULL
of	NULL
nuclear	NULL
extracts	NULL
(	NULL
3	NULL
ug	NULL
proteins	NULL
per	NULL
lane	NULL
)	NULL
prepared	NULL
from	NULL
NK	NULL
cells	NULL
cultured	NULL
for	NULL
1	NULL
h	NULL
in	NULL
medium	NULL
alone	NULL
(	NULL
None	NULL
)	NULL
,	NULL
E	NULL
,	NULL
or	NULL
EA	NULL
added	NULL
,	NULL
as	NULL
indicated	NULL
,	NULL
were	NULL
assayed	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
NFAT	NULL
site	NULL
in	NULL
the	NULL
human	NULL
TNF	NULL
promoter	NULL
using	NULL
the	NULL
NF-k3	NULL
probe	NULL
.	NULL

The	NULL
sample	NULL
from	NULL
EA-stimulated	NULL
cells	NULL
was	NULL
also	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
None	NULL
)	NULL
or	NULL
presence	NULL
of	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
listed	NULL
cold	NULL
double-stranded	NULL
DNA	NULL
oligonucleotides	NULL
before	NULL
adding	NULL
the	NULL
P-labeled	NULL
NF-	NULL
¬´	NULL
3	NULL
probe	NULL
.	NULL

NFAT	NULL
,	NULL
the	NULL
shift	NULL
caused	NULL
by	NULL
binding	NULL
of	NULL
the	NULL
factor	NULL
to	NULL
the	NULL
probe	NULL
;	NULL
FP	NULL
,	NULL
the	NULL
position	NULL
of	NULL
the	NULL
unbound/free	NULL
probe	NULL
;	NULL
p	NULL
,	NULL
probe	NULL
alone	NULL
.	NULL

The	NULL
appearance	NULL
of	NULL
two	NULL
lower	NULL
bands	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
both	NULL
specific	NULL
and	NULL
non	NULL
specific	NULL
competitors	NULL
likely	NULL
represents	NULL
artefactual	NULL
binding	NULL
of	NULL
proteins	NULL
in	NULL
the	NULL
extracts	NULL
,	NULL
when	NULL
the	NULL
majority	NULL
of	NULL
specific	NULL
factors	NULL
has	NULL
been	NULL
competed	NULL
by	NULL
the	NULL
excess	NULL
of	NULL
the	NULL
corresponding	NULL
probe	NULL
.	NULL

tracellular	NULL
Ca	NULL
#	NULL
*	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
our	NULL
previous	NULL
data	NULL
(	NULL
8	NULL
)	NULL
,	NULL
or	NULL
pretreatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
CsA	NULL
.	NULL

Accumulation	NULL
of	NULL
GM-CSF	NULL
mRNA	NULL
induced	NULL
upon	NULL
CD16	NULL
stimulation	NULL
,	NULL
like	NULL
that	NULL
of	NULL
TNF	NULL
(	NULL
8	NULL
)	NULL
,	NULL
depends	NULL
on	NULL
induced	NULL
gene	NULL
transcription	NULL
and	NULL
is	NULL
inhibited	NULL
in	NULL
cells	NULL
pretreated	NULL
with	NULL
Act	NULL
D	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
)	NULL
.	NULL

Pretreatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
protein	NULL
synthesis	NULL
inhibitors	NULL
resulted	NULL
in	NULL
overexpression	NULL
of	NULL
CD16-induced	NULL
TNF	NULL
and	NULL
only	NULL
minimal	NULL
inhibition	NULL
of	NULL
GM-CSF	NULL
mRNA	NULL
accumulation	NULL
under	NULL
conditions	NULL
in	NULL
which	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
CsA	NULL
was	NULL
still	NULL
evident	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
CD16-induced	NULL
transcription	NULL
of	NULL
these	NULL
genes	NULL
involves	NULL
activation	NULL
of	NULL
a	NULL
CsA-sensitive	NULL
,	NULL
Ca**-dependent	NULL
804	NULL
NFAT	NULL
Activation	NULL
in	NULL
NK	NULL
Cells	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
0	NULL
15	NULL
30	NULL
120	NULL
Stimulus	NULL
None	NULL
None	NULL
EA	NULL
None	NULL
EA	NULL
None	NULL
EA	NULL
P	NULL
wwom	NULL
see	NULL
gul	NULL
duce	NULL
gul	NULL
#	NULL
fuse	NULL
NFAT	NULL
U	NULL
-|	NULL
P	NULL
>	NULL
l	NULL
AP-1	NULL
‚Äú	NULL
H	NULL
‚Äò	NULL
J	NULL
H	NULL
bind	NULL
4	NULL
-	NULL
Lu	NULL
1h	NULL
Figure	NULL
4	NULL
.	NULL

Kinetics	NULL
of	NULL
NFAT	NULL
activation	NULL
in	NULL
CD16-stimulated	NULL
human	NULL
NK	NULL
cells	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
NK	NULL
cells	NULL
incubated	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
in	NULL
medium	NULL
without	NULL
(	NULL
None	NULL
)	NULL
or	NULL
with	NULL
EA	NULL
.	NULL

They	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
using	NULL
the	NULL
NFAT	NULL
mIl-4	NULL
(	NULL
top	NULL
panel	NULL
)	NULL
and	NULL
the	NULL
AP-1	NULL
probe	NULL
(	NULL
bottom	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
shifts	NULL
due	NULL
to	NULL
NFAT	NULL
and	NULL
AP-1	NULL
binding	NULL
to	NULL
the	NULL
probes	NULL
are	NULL
indicated	NULL
.	NULL

pathway	NULL
using	NULL
elements	NULL
constitutively	NULL
present	NULL
in	NULL
NK	NULL
cells	NULL
.	NULL

CD16-induced	NULL
Activation	NULL
of	NULL
NFAT	NULL
.	NULL

-	NULL
'To	NULL
determine	NULL
whether	NULL
NFAT	NULL
is	NULL
expressed	NULL
in	NULL
NK	NULL
cells	NULL
and	NULL
is	NULL
activated	NULL
upon	NULL
CD16	NULL
stimulation	NULL
,	NULL
we	NULL
performed	NULL
EMSA	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
CD16-stimulated	NULL
cells	NULL
and	NULL
oligonucleotide	NULL
probes	NULL
corresponding	NULL
to	NULL
the	NULL
conserved	NULL
NFAT	NULL
distal	NULL
binding	NULL
sequences	NULL
in	NULL
the	NULL
human	NULL
IL-2	NULL
,	NULL
the	NULL
murine	NULL
IL-4	NULL
,	NULL
and	NULL
the	NULL
human	NULL
TNF	NULL
and	NULL
GM-CSF	NULL
promoters	NULL
.	NULL

Binding	NULL
of	NULL
NFAT	NULL
to	NULL
the	NULL
first	NULL
probe	NULL
depends	NULL
on	NULL
its	NULL
association	NULL
with	NULL
AP-1	NULL
(	NULL
34	NULL
,	NULL
37	NULL
)	NULL
,	NULL
whereas	NULL
that	NULL
to	NULL
the	NULL
IL-4	NULL
probe	NULL
is	NULL
independent	NULL
of	NULL
other	NULL
factors	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Stimulation	NULL
of	NULL
NK	NULL
cells	NULL
with	NULL
anti-CD16	NULL
mAb	NULL
,	NULL
immune	NULL
complexes	NULL
,	NULL
or	NULL
PDBu/ionomycin	NULL
for	NULL
1	NULL
h	NULL
activated	NULL
NFAT	NULL
,	NULL
detected	NULL
with	NULL
the	NULL
NFAT	NULL
hull-2	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
)	NULL
.	NULL

Immune	NULL
complex-	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
)	NULL
and	NULL
anti-CD16	NULL
mAb	NULL
,	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
induced	NULL
activation	NULL
was	NULL
prevented	NULL
chelating	NULL
extracellular	NULL
Ca	NULL
#	NULL
*	NULL
with	NULL
EGTA	NULL
or	NULL
pretreating	NULL
the	NULL
cells	NULL
with	NULL
CsA	NULL
.	NULL

The	NULL
complex	NULL
activated	NULL
by	NULL
CD16	NULL
was	NULL
efficiently	NULL
and	NULL
specifically	NULL
competed	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
)	NULL
by	NULL
the	NULL
NFAT	NULL
hull	NULL
>	NULL
2	NULL
,	NULL
by	NULL
each	NULL
of	NULL
two	NULL
other	NULL
cold	NULL
oligonucleotides	NULL
containing	NULL
NFAT	NULL
binding	NULL
None	NULL
Emetine	NULL
None	NULL
Emetine	NULL
Stimulus	NULL
None	NULL
E	NULL
EA	NULL
None	NULL
E	NULL
EA	NULL
None	NULL
E	NULL
EA	NULL
None	NULL
E	NULL
EA	NULL
wu	NULL
memory	NULL
came	NULL
muse	NULL
m	NULL
m	NULL
nFat	NULL
bd	NULL
1¬∞	NULL
[	NULL
1	NULL
]	NULL
wz	NULL
=d	NULL
t_	NULL
.	NULL

~-	NULL
Time	NULL
30	NULL
min	NULL
120	NULL
min	NULL
Figure	NULL
5	NULL
.	NULL

Effect	NULL
of	NULL
protein	NULL
synthesis	NULL
inhibition	NULL
on	NULL
CD16-induced	NULL
NFAT	NULL
activation	NULL
.	NULL

NK	NULL
cells	NULL
(	NULL
6	NULL
x	NULL
10	NULL
``	NULL
per	NULL
sample	NULL
)	NULL
were	NULL
incubated	NULL
without	NULL
(	NULL
None	NULL
)	NULL
or	NULL
with	NULL
emetine	NULL
for	NULL
30	NULL
min	NULL
,	NULL
after	NULL
which	NULL
identical	NULL
10	NULL
``	NULL
cell	NULL
aliquots	NULL
were	NULL
incubated	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
in	NULL
medium	NULL
without	NULL
(	NULL
None	NULL
)	NULL
or	NULL
with	NULL
E	NULL
or	NULL
EA	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
analyzed	NULL
by	NULL
EMSA	NULL
with	NULL
the	NULL
NFAT	NULL
mIl-4	NULL
probe	NULL
.	NULL

The	NULL
shift	NULL
resulting	NULL
from	NULL
NFAT	NULL
is	NULL
indicated	NULL
.	NULL

sequences	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
cytokines	NULL
produced	NULL
by	NULL
NK	NULL
cells	NULL
(	NULL
GM-550	NULL
from	NULL
the	NULL
GM-CSF/IL-3	NULL
enhancer	NULL
[	NULL
17	NULL
]	NULL
and	NULL
NF-	NULL
¬´	NULL
3	NULL
from	NULL
the	NULL
TNF	NULL
promoter	NULL
[	NULL
19	NULL
]	NULL
)	NULL
,	NULL
but	NULL
not	NULL
by	NULL
SP1	NULL
(	NULL
containing	NULL
an	NULL
unrelated	NULL
sequence	NULL
)	NULL
,	NULL
and	NULL
by	NULL
excess	NULL
cold	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
an	NULL
additional	NULL
NFAT	NULL
binding	NULL
sequence	NULL
(	NULL
NFAT	NULL
mIl-4	NULL
)	NULL
or	NULL
to	NULL
the	NULL
AP-1	NULL
binding	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
B	NULL
)	NULL
.	NULL

In	NULL
EMSA	NULL
performed	NULL
with	NULL
the	NULL
labeled	NULL
NF-	NULL
¬´	NULL
3	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
C	NULL
)	NULL
,	NULL
a	NULL
shift	NULL
was	NULL
detected	NULL
that	NULL
was	NULL
inhibited	NULL
by	NULL
all	NULL
cold	NULL
oligonucleotides	NULL
used	NULL
that	NULL
contain	NULL
NFAT	NULL
binding	NULL
sites	NULL
(	NULL
NF-	NULL
¬´	NULL
3	NULL
,	NULL
NFAT	NULL
hull-2	NULL
,	NULL
and	NULL
mIL-4	NULL
)	NULL
,	NULL
but	NULL
not	NULL
by	NULL
SP1	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
the	NULL
labeled	NULL
GM-550	NULL
oligonucleotide	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
CD16-induced	NULL
transcription	NULL
of	NULL
TNF	NULL
and	NULL
GM-CSF	NULL
correlates	NULL
with	NULL
activation	NULL
of	NULL
NFAT	NULL
,	NULL
the	NULL
NFAT	NULL
expressed	NULL
in	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
have	NULL
identical	NULL
DNA	NULL
binding	NULL
specificity	NULL
,	NULL
and	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
both	NULL
is	NULL
enhanced	NULL
upon	NULL
association	NULL
with	NULL
AP-1	NULL
.	NULL

Protein	NULL
Synthesis	NULL
Requirement	NULL
for	NULL
CD16-induced	NULL
NFAT	NULL
Activation	NULL
.	NULL

-	NULL
NFAT	NULL
activation	NULL
was	NULL
detected	NULL
with	NULL
the	NULL
NFAT	NULL
mIL4	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
top	NULL
)	NULL
and	NULL
the	NULL
NFAT	NULL
hull-2	NULL
,	NULL
AP-1-dependent	NULL
,	NULL
probe	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
within	NULL
15	NULL
min	NULL
stimulation	NULL
of	NULL
CD16	NULL
,	NULL
and	NULL
it	NULL
was	NULL
sustained	NULL
up	NULL
to	NULL
2	NULL
h.	NULL
AP-1	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
CD16-stimulated	NULL
NK	NULL
cells	NULL
contributed	NULL
to	NULL
the	NULL
observed	NULL
NFAT	NULL
binding	NULL
to	NULL
the	NULL
NFAT	NULL
hull-2	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
B	NULL
)	NULL
;	NULL
therefore	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
in	NULL
vitro	NULL
AP-1	NULL
activity	NULL
in	NULL
the	NULL
same	NULL
samples	NULL
.	NULL

In	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
NK	NULL
cells	NULL
used	NULL
here	NULL
,	NULL
AP-1	NULL
was	NULL
detectable	NULL
by	NULL
EMSA	NULL
before	NULL
addition	NULL
of	NULL
any	NULL
stimulus	NULL
(	NULL
time	NULL
0	NULL
)	NULL
.	NULL

CD16	NULL
stimulation	NULL
induced	NULL
AP-1	NULL
activity	NULL
higher	NULL
than	NULL
background	NULL
within	NULL
30	NULL
min	NULL
and	NULL
sustained	NULL
up	NULL
to	NULL
2	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
bottom	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
NFAT	NULL
activation	NULL
is	NULL
an	NULL
early	NULL
step	NULL
in	NULL
the	NULL
CD16	NULL
activation	NULL
pathway	NULL
and	NULL
involves	NULL
two	NULL
components	NULL
detectable	NULL
in	NULL
vitro	NULL
:	NULL
activation	NULL
of	NULL
NFAT	NULL
on	NULL
its	NULL
own	NULL
and	NULL
increased	NULL
AP-1	NULL
activity	NULL
.	NULL

To	NULL
test	NULL
the	NULL
hypothesis	NULL
that	NULL
the	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
involved	NULL
in	NULL
cytokine	NULL
gene	NULL
transcription	NULL
regulated	NULL
by	NULL
CD16	NULL
stimulation	NULL
is	NULL
(	NULL
are	NULL
)	NULL
directly	NULL
activated	NULL
from	NULL
a	NULL
preformed	NULL
pool	NULL
,	NULL
we	NULL
analyzed	NULL
CD16-induced	NULL
NFAT	NULL
activation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
.	NULL

NFAT	NULL
activation	NULL
in	NULL
NK	NULL
cells	NULL
pretreated	NULL
with	NULL
emetine	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
was	NULL
sustained	NULL
throughout	NULL
the	NULL
2-h	NULL
stimulation	NULL
with	NULL
FeyRIII	NULL
ligands	NULL
,	NULL
as	NULL
assessed	NULL
in	NULL
EMSA	NULL
using	NULL
the	NULL
AP-1-independent	NULL
NFAT	NULL
mIL-4	NULL
probe	NULL
.	NULL

NFAT	NULL
activity	NULL
detected	NULL
805	NULL
Aramburu	NULL
et	NULL
al	NULL
.	NULL

NK	NULL
cell	NULL
cytosolic	NULL
extract	NULL
NFAT	NULL
IL-2	NULL
Probe	NULL
NFAT	NULL
IL	NULL
NFAT	NULL
IL-2	NULL
Extract	NULL
NC	NULL
N+C	NULL
Competitor	NULL
-	NULL
.	NULL

NFAT	NULL
SPI	NULL
AP-1	NULL
-	NULL
NFAT	NULL
Competitor	NULL
-	NULL
NFAT	NULL
AP-1	NULL
IL~4	NULL
IL-2	NULL
IL-2	NULL
IL-2	NULL
+=	NULL
6	NULL
%	NULL
two	NULL
og	NULL
NEAT	NULL
u	NULL
‚Äú	NULL
W	NULL
H	NULL
‚Äú	NULL
NEAT	NULL
Hp	NULL
FP	NULL
?	NULL

-	NULL
woth	NULL
ad	NULL
Ad	NULL
44	NULL
4	NULL
Figure	NULL
6	NULL
.	NULL

-	NULL
Detection	NULL
of	NULL
NFAT	NULL
in	NULL
cytoplasmic	NULL
extracts	NULL
of	NULL
nonstimulated	NULL
'	NULL
NK	NULL
cells	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Identical	NULL
aliquots	NULL
of	NULL
cytoplasmic	NULL
extracts	NULL
from	NULL
nonstimulated	NULL
NK	NULL
cells	NULL
(	NULL
7	NULL
ug	NULL
per	NULL
sample	NULL
)	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
with	NULL
NFAT	NULL
and	NULL
NFAT	NULL
hull	NULL
;	NULL
2	NULL
oligonucleotide	NULL
probes	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
shift	NULL
was	NULL
assessed	NULL
for	NULL
each	NULL
probe	NULL
by	NULL
competition	NULL
with	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
NFAT	NULL
(	NULL
hull-2	NULL
and	NULL
mIL-4	NULL
)	NULL
cold	NULL
probes	NULL
,	NULL
cold	NULL
SP1	NULL
,	NULL
and	NULL
AP-1	NULL
,	NULL
as	NULL
indicated	NULL
;	NULL
-	NULL
,	NULL
no	NULL
cold	NULL
oligonucleotide	NULL
added	NULL
.	NULL

(	NULL
B	NULL
)	NULL
EMSA	NULL
were	NULL
performed	NULL
with	NULL
nuclear	NULL
extracts	NULL
(	NULL
N	NULL
,	NULL
3	NULL
ug	NULL
per	NULL
lane	NULL
)	NULL
from	NULL
nonstimulated	NULL
cells	NULL
,	NULL
cytoplasmic	NULL
extracts	NULL
(	NULL
C	NULL
,	NULL
7	NULL
ug	NULL
per	NULL
lane	NULL
)	NULL
from	NULL
the	NULL
same	NULL
cells	NULL
,	NULL
or	NULL
a	NULL
mixture	NULL
of	NULL
both	NULL
(	NULL
N+C	NULL
)	NULL
.	NULL

Identical	NULL
aliquots	NULL
of	NULL
the	NULL
mixture	NULL
of	NULL
cytoplasmic	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
without	NULL
(	NULL
-	NULL
)	NULL
or	NULL
with	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
NFAT	NULL
hull-2	NULL
or	NULL
AP-1	NULL
cold	NULL
oligonucleotides	NULL
,	NULL
as	NULL
indicated	NULL
,	NULL
to	NULL
assess	NULL
DNA	NULL
binding	NULL
specificity	NULL
and	NULL
AP-1	NULL
dependence	NULL
.	NULL

The	NULL
shift	NULL
resulting	NULL
from	NULL
NFAT	NULL
binding	NULL
to	NULL
the	NULL
probes	NULL
and	NULL
the	NULL
position	NULL
of	NULL
free	NULL
probes	NULL
are	NULL
indicated	NULL
.	NULL

within	NULL
30	NULL
min	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
the	NULL
inhibitor	NULL
,	NULL
but	NULL
it	NULL
was	NULL
reproducibly	NULL
decreased	NULL
compared	NULL
to	NULL
controls	NULL
after	NULL
2-h	NULL
stimulation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
emetine	NULL
,	NULL
possibly	NULL
reflecting	NULL
the	NULL
dis-appearence	NULL
and	NULL
lack	NULL
of	NULL
replacement	NULL
of	NULL
the	NULL
endogenous	NULL
NFAT	NULL
pool	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
protein	NULL
synthesis	NULL
.	NULL

Expression	NULL
of	NULL
Cytoplasmic	NULL
NFAT	NULL
in	NULL
Nonstimulated	NULL
NK	NULL
Cells	NULL
.	NULL

To	NULL
determine	NULL
directly	NULL
whether	NULL
CD16	NULL
stimulation	NULL
activates	NULL
a	NULL
preformed	NULL
NFAT	NULL
pool	NULL
in	NULL
nonstimulated	NULL
NK	NULL
cells	NULL
and	NULL
induces	NULL
its	NULL
translocation	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
presence	NULL
of	NULL
NFAT	NULL
in	NULL
cytosolic	NULL
extracts	NULL
of	NULL
nonstimulated	NULL
NK	NULL
cells	NULL
.	NULL

The	NULL
NFAT	NULL
mIL-4	NULL
probe	NULL
detected	NULL
NFAT	NULL
in	NULL
cytoplasmic	NULL
extracts	NULL
from	NULL
these	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
A	NULL
)	NULL
,	NULL
and	NULL
DNA	NULL
binding	NULL
was	NULL
inhibited	NULL
by	NULL
an	NULL
excess	NULL
of	NULL
the	NULL
same	NULL
cold	NULL
probe	NULL
,	NULL
but	NULL
not	NULL
by	NULL
the	NULL
AP-1-dependent	NULL
NFAT	NULL
hull-2	NULL
or	NULL
the	NULL
AP-1	NULL
oligonucleo-tides	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
cytoplasmic	NULL
NFAT	NULL
was	NULL
not	NULL
detectable	NULL
using	NULL
the	NULL
NFAT	NULL
hull-2	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
A	NULL
,	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

A	NULL
band	NULL
with	NULL
mobility	NULL
faster	NULL
than	NULL
that	NULL
of	NULL
the	NULL
NFAT	NULL
complex	NULL
was	NULL
observed	NULL
with	NULL
this	NULL
probe	NULL
in	NULL
the	NULL
cytoplasmic	NULL
extracts	NULL
,	NULL
was	NULL
not	NULL
competed	NULL
with	NULL
excess	NULL
cold	NULL
probe	NULL
and	NULL
is	NULL
likely	NULL
caused	NULL
by	NULL
nonspecific	NULL
binding	NULL
.	NULL

NFAT	NULL
binding	NULL
to	NULL
the	NULL
NFAT	NULL
hull-2	NULL
probe	NULL
was	NULL
reconstituted	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
B	NULL
,	NULL
lane	NULL
N+C	NULL
)	NULL
when	NULL
the	NULL
cytoplasmic	NULL
extracts	NULL
(	NULL
lane	NULL
C	NULL
)	NULL
were	NULL
combined	NULL
with	NULL
nuclear	NULL
extracts	NULL
(	NULL
lane	NULL
N	NULL
)	NULL
,	NULL
containing	NULL
AP-1	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
but	NULL
not	NULL
NFAT	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
B	NULL
,	NULL
lane	NULL
N	NULL
)	NULL
,	NULL
prepared	NULL
from	NULL
the	NULL
same	NULL
nonstimulated	NULL
NK	NULL
cells	NULL
.	NULL

Both	NULL
cold	NULL
AP-1	NULL
and	NULL
NFAT	NULL
hull-2	NULL
oligonucleotides	NULL
,	NULL
but	NULL
not	NULL
unrelated	NULL
oligonucleotides	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
efficiently	NULL
inhibited	NULL
NFAT	NULL
binding	NULL
to	NULL
the	NULL
probe	NULL
.	NULL

NFATp	NULL
and	NULL
NFAT	NULL
Expression	NULL
and	NULL
Activation	NULL
in	NULL
NK	NULL
Cells	NULL
.	NULL

A	NULL
NK	NULL
cells	NULL
B	NULL
Turkst	NULL
None	NULL
EATS	NULL
(	NULL
1	NULL
h	NULL
)	NULL
EATS	NULL
(	NULL
1	NULL
b	NULL
)	NULL
``	NULL
.	NULL

-	NULL
Wi	NULL
q	NULL
ti	NULL
}	NULL
PF	NULL
bs	NULL
|	NULL
Figure	NULL
7	NULL
.	NULL

Identification	NULL
of	NULL
NFATp	NULL
in	NULL
NK	NULL
cells	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Nuclear	NULL
extracts	NULL
from	NULL
NK	NULL
cells	NULL
,	NULL
incubated	NULL
in	NULL
medium	NULL
without	NULL
(	NULL
None	NULL
)	NULL
or	NULL
with	NULL
EA	NULL
for	NULL
1	NULL
h	NULL
,	NULL
were	NULL
analyzed	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
NFATp	NULL
and	NULL
NFATe	NULL
using	NULL
specific	NULL
antibodies	NULL
and	NULL
EMSA	NULL
in	NULL
supershift	NULL
assays	NULL
.	NULL

Before	NULL
adding	NULL
the	NULL
labeled	NULL
NFAT	NULL
mIl-4	NULL
probe	NULL
,	NULL
identical	NULL
aliquots	NULL
of	NULL
the	NULL
samples	NULL
(	NULL
3	NULL
ug	NULL
per	NULL
lane	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
without	NULL
(	NULL
-	NULL
)	NULL
or	NULL
with	NULL
NRS	NULL
,	NULL
mAb	NULL
B159.5	NULL
,	NULL
IgG1	NULL
(	NULL
CD56	NULL
)	NULL
,	NULL
anti-NFATp	NULL
rabbit	NULL
antiserum	NULL
(	NULL
072	NULL
)	NULL
,	NULL
anti-NFATe	NULL
mAb	NULL
,	NULL
IgG1	NULL
(	NULL
7A6	NULL
)	NULL
,	NULL
or	NULL
anti-NFATp	NULL
plus	NULL
anti-NFATe	NULL
antibodies	NULL
(	NULL
72	NULL
+	NULL
7A6	NULL
)	NULL
.	NULL

In	NULL
the	NULL
right	NULL
panel	NULL
,	NULL
NFATp	NULL
72	NULL
antiserum	NULL
,	NULL
preincubated	NULL
(	NULL
30	NULL
min	NULL
,	NULL
4¬∞C	NULL
)	NULL
in	NULL
medium	NULL
alone	NULL
(	NULL
-	NULL
)	NULL
,	NULL
with	NULL
its	NULL
cognate	NULL
peptide	NULL
(	NULL
p72	NULL
)	NULL
or	NULL
an	NULL
irrelevant	NULL
peptide	NULL
(	NULL
p25	NULL
)	NULL
,	NULL
was	NULL
added	NULL
to	NULL
identical	NULL
aliquots	NULL
(	NULL
3	NULL
ug	NULL
per	NULL
lane	NULL
)	NULL
of	NULL
a	NULL
nuclear	NULL
extract	NULL
from	NULL
1-h	NULL
EA-stimulated	NULL
NK	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
samples	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
and	NULL
supershift	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
first	NULL
two	NULL
lanes	NULL
are	NULL
aliquots	NULL
from	NULL
the	NULL
same	NULL
nuclear	NULL
extract	NULL
preincubated	NULL
with	NULL
no	NULL
antiserum	NULL
(	NULL
-	NULL
)	NULL
or	NULL
with	NULL
a	NULL
NRS	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
no	NULL
peptide	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Identical	NULL
aliquots	NULL
(	NULL
3	NULL
ug	NULL
per	NULL
lane	NULL
)	NULL
of	NULL
a	NULL
nuclear	NULL
extract	NULL
from	NULL
2	NULL
x	NULL
10	NULL
``	NULL
4-h	NULL
PDBu	NULL
plus	NULL
ionomycin	NULL
(	NULL
P/T	NULL
)	NULL
-stimulated	NULL
Jurkat	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
each	NULL
of	NULL
the	NULL
same	NULL
antibodies	NULL
as	NULL
in	NULL
A	NULL
and	NULL
subjected	NULL
to	NULL
EMSA	NULL
.	NULL

Antibodies	NULL
were	NULL
used	NULL
at	NULL
a	NULL
final	NULL
dilution	NULL
of	NULL
1/250	NULL
from	NULL
the	NULL
original	NULL
serum	NULL
(	NULL
rabbit	NULL
)	NULL
or	NULL
ascitic	NULL
fluid	NULL
(	NULL
mouse	NULL
)	NULL
;	NULL
peptides	NULL
were	NULL
used	NULL
at	NULL
4	NULL
ug/ml	NULL
final	NULL
concentrations	NULL
.	NULL

NFAT	NULL
binding	NULL
to	NULL
the	NULL
NFAT	NULL
mIl-4	NULL
probe	NULL
and	NULL
the	NULL
supershift	NULL
induced	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
Ab	NULL
are	NULL
indicated	NULL
with	NULL
closed	NULL
and	NULL
open	NULL
arrowheads	NULL
,	NULL
respectively	NULL
.	NULL

Two	NULL
related	NULL
but	NULL
distinct	NULL
proteins	NULL
,	NULL
NFATp	NULL
and	NULL
NFAT	NULL
,	NULL
mediate	NULL
NFAT	NULL
binding	NULL
activity	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
.	NULL

To	NULL
analyze	NULL
the	NULL
relative	NULL
contribution	NULL
of	NULL
these	NULL
elements	NULL
to	NULL
the	NULL
NFAT	NULL
activity	NULL
in	NULL
CD16-stimulated	NULL
NK	NULL
cells	NULL
,	NULL
we	NULL
used	NULL
an	NULL
antiserum	NULL
against	NULL
the	NULL
murine	NULL
NFATp	NULL
peptide	NULL
72	NULL
(	NULL
amino	NULL
acids	NULL
206-232	NULL
)	NULL
(	NULL
29	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
an	NULL
mAb	NULL
to	NULL
the	NULL
human	NULL
NFATe	NULL
(	NULL
mAb	NULL
7A6	NULL
)	NULL
(	NULL
30	NULL
)	NULL
in	NULL
supershift	NULL
experiments	NULL
.	NULL

Most	NULL
of	NULL
the	NULL
NFAT	NULL
complex	NULL
detected	NULL
with	NULL
the	NULL
NFAT	NULL
mIl-4	NULL
probe	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
1-h	NULL
CD16-stimulated	NULL
NK	NULL
cells	NULL
was	NULL
supershifted	NULL
by	NULL
the	NULL
anti-NFATp	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
A	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
using	NULL
anti-NFATp	NULL
antiserum	NULL
67.1	NULL
(	NULL
35	NULL
)	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
30-min	NULL
and	NULL
2-h	NULL
CD16-stimulated	NULL
NK	NULL
cells	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

An	NULL
irrelevant	NULL
antiserum	NULL
(	NULL
nonimmune	NULL
rabbit	NULL
serum	NULL
[	NULL
NRS	NULL
]	NULL
)	NULL
and	NULL
an	NULL
isotype-matched	NULL
anti-CD56	NULL
mAb	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
relative	NULL
mobility	NULL
of	NULL
the	NULL
complex	NULL
,	NULL
and	NULL
none	NULL
of	NULL
the	NULL
antibodies	NULL
bound	NULL
the	NULL
DNA	NULL
probe	NULL
alone	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
supershift	NULL
induced	NULL
by	NULL
the	NULL
anti-NFATp	NULL
antibody	NULL
was	NULL
specifically	NULL
prevented	NULL
by	NULL
the	NULL
cognate	NULL
peptide	NULL
72	NULL
,	NULL
but	NULL
not	NULL
by	NULL
a	NULL
different	NULL
peptide	NULL
(	NULL
peptide	NULL
25	NULL
,	NULL
amino	NULL
acids	NULL
685-703	NULL
in	NULL
the	NULL
murine	NULL
NFATp	NULL
)	NULL
(	NULL
29	NULL
)	NULL
.	NULL

The	NULL
anti-NFATe	NULL
mAb	NULL
7A6	NULL
induced	NULL
no	NULL
detectable	NULL
supershift	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
A	NULL
)	NULL
,	NULL
nor	NULL
did	NULL
it	NULL
increase	NULL
the	NULL
amount	NULL
of	NULL
supershifted	NULL
complex	NULL
when	NULL
combined	NULL
with	NULL
the	NULL
72	NULL
Ab	NULL
.	NULL

Consistent	NULL
with	NULL
these	NULL
results	NULL
,	NULL
NFATe	NULL
was	NULL
detected	NULL
neither	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
short-term	NULL
stimulated	NULL
cells	NULL
nor	NULL
in	NULL
cytosolic	NULL
preparations	NULL
of	NULL
nonstimulated	NULL
or	NULL
4-h	NULL
stimulated	NULL
NK	NULL
cells	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

On	NULL
the	NULL
contrary	NULL
(	NULL
Fig	NULL
.	NULL

806	NULL
NFAT	NULL
Activation	NULL
in	NULL
NK	NULL
Cells	NULL
aeNFATp	NULL
NRS	NULL
Mr	NULL
x	NULL
10¬∞	NULL
T	NULL
NK	NULL
COS	NULL
T	NULL
NK	NULL
COS	NULL
200	NULL
wg	NULL
u	NULL
¬ª	NULL
97	NULL
68	NULL
Figure	NULL
8	NULL
.	NULL

-	NULL
Biochemical	NULL
characteristics	NULL
of	NULL
NK	NULL
cell	NULL
NFATp	NULL
.	NULL

Whole-cell	NULL
lysates	NULL
from	NULL
PHA	NULL
blasts	NULL
(	NULL
T	NULL
)	NULL
,	NULL
NK	NULL
,	NULL
or	NULL
COS-7	NULL
cells	NULL
were	NULL
resolved	NULL
in	NULL
SDS-PAGE	NULL
(	NULL
7.5	NULL
%	NULL
acrylamide	NULL
,	NULL
reducing	NULL
conditions	NULL
)	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
with	NULL
the	NULL
anti-NFATp	NULL
rabbit	NULL
antiserum	NULL
067.1	NULL
(	NULL
left	NULL
panel	NULL
,	NULL
eNFATp	NULL
)	NULL
and	NULL
a	NULL
nonimmune	NULL
rabbit	NULL
serum	NULL
(	NULL
right	NULL
panel	NULL
,	NULL
NRS	NULL
)	NULL
as	NULL
control	NULL
,	NULL
followed	NULL
by	NULL
ECL	NULL
detection	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
T	NULL
and	NULL
NK	NULL
cell	NULL
samples	NULL
were	NULL
from	NULL
2	NULL
x	NULL
105	NULL
cells	NULL
,	NULL
the	NULL
COS	NULL
cell	NULL
sample	NULL
was	NULL
from	NULL
10	NULL
%	NULL
cells	NULL
;	NULL
antisera	NULL
were	NULL
used	NULL
at	NULL
a	NULL
2	NULL
x	NULL
10-	NULL
final	NULL
dilution	NULL
.	NULL

Positions	NULL
of	NULL
molecular	NULL
size	NULL
markers	NULL
are	NULL
indicated	NULL
.	NULL

7	NULL
B	NULL
)	NULL
,	NULL
the	NULL
anti-NFATe	NULL
mAb	NULL
efficiently	NULL
supershifted	NULL
the	NULL
NFAT	NULL
complex	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
Jurkat	NULL
cells	NULL
or	NULL
from	NULL
PHA	NULL
lymphoblasts	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
stimulated	NULL
for	NULL
4	NULL
h	NULL
with	NULL
PDBu/	NULL
ionomycin	NULL
,	NULL
conditions	NULL
in	NULL
which	NULL
NFATe	NULL
is	NULL
induced	NULL
and	NULL
activated	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Only	NULL
a	NULL
small	NULL
portion	NULL
of	NULL
the	NULL
complex	NULL
was	NULL
supershifted	NULL
by	NULL
the	NULL
anti-NFATp	NULL
antibody	NULL
in	NULL
the	NULL
Jurkat	NULL
T	NULL
cell	NULL
line	NULL
.	NULL

These	NULL
results	NULL
confirm	NULL
that	NULL
the	NULL
antibodies	NULL
do	NULL
not	NULL
detect	NULL
cross-reactive	NULL
determinants	NULL
in	NULL
the	NULL
two	NULL
NFATp	NULL
.	NULL

SDS-PAGE	NULL
of	NULL
total	NULL
lysates	NULL
from	NULL
non	NULL
stimulated	NULL
NK	NULL
cells	NULL
followed	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
the	NULL
anti-NFATp	NULL
antiserum	NULL
67.1	NULL
resolved	NULL
a	NULL
specific	NULL
prominent	NULL
band	NULL
of	NULL
~120	NULL
kD	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
,	NULL
similar	NULL
in	NULL
size	NULL
and	NULL
relative	NULL
density	NULL
to	NULL
that	NULL
detected	NULL
in	NULL
PHA	NULL
blast	NULL
lysates	NULL
,	NULL
and	NULL
corresponding	NULL
to	NULL
the	NULL
phosphorylated	NULL
(	NULL
cytoplasmic	NULL
)	NULL
form	NULL
of	NULL
NFATp	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Bands	NULL
with	NULL
lower	NULL
relative	NULL
molecular	NULL
weight	NULL
detected	NULL
in	NULL
both	NULL
the	NULL
NK	NULL
and	NULL
T	NULL
cell	NULL
lysates	NULL
likely	NULL
represent	NULL
partially	NULL
dephosphorylated	NULL
NFATp	NULL
and/or	NULL
their	NULL
degradation	NULL
products	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
results	NULL
from	NULL
EMSA	NULL
,	NULL
NFATe	NULL
mRNA	NULL
was	NULL
undetectable	NULL
in	NULL
nonstimulated	NULL
NK	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
,	NULL
but	NULL
it	NULL
accumulated	NULL
at	NULL
levels	NULL
significantly	NULL
higher	NULL
than	NULL
background	NULL
within	NULL
2-h	NULL
stimulation	NULL
with	NULL
CD16	NULL
ligands	NULL
.	NULL

Induction	NULL
of	NULL
its	NULL
expression	NULL
was	NULL
,	NULL
as	NULL
previously	NULL
reported	NULL
(	NULL
30	NULL
)	NULL
,	NULL
CsA-sensitive	NULL
,	NULL
and	NULL
it	NULL
did	NULL
not	NULL
depend	NULL
on	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
,	NULL
but	NULL
depended	NULL
on	NULL
RNA	NULL
synthesis	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
newly	NULL
synthesized	NULL
NFAT	NULL
contributes	NULL
to	NULL
the	NULL
NFAT	NULL
activity	NULL
observed	NULL
at	NULL
later	NULL
times	NULL
after	NULL
CD16	NULL
stimulation	NULL
,	NULL
we	NULL
analyzed	NULL
its	NULL
presence	NULL
in	NULL
cytoplasmic	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
NK	NULL
cells	NULL
by	NULL
EMSA	NULL
.	NULL

NFAT	NULL
protein	NULL
was	NULL
undetectable	NULL
in	NULL
nonstimulated	NULL
cells	NULL
and	NULL
in	NULL
cells	NULL
stimulated	NULL
up	NULL
to	NULL
4	NULL
h	NULL
with	NULL
immune	NULL
complexes	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
phorbol	NULL
esters	NULL
and	NULL
a	NULL
Ca	NULL
#	NULL
+*	NULL
ionophore	NULL
.	NULL

The	NULL
anti-NFATe	NULL
Ab	NULL
induced	NULL
supershift	NULL
when	NULL
added	NULL
to	NULL
nuclear	NULL
extracts	NULL
from	NULL
phorbol	NULL
ester	NULL
and	NULL
ionomycin-treated	NULL
PHA	NULL
lymphoblasts	NULL
and	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
when	NULL
added	NULL
to	NULL
NK	NULL
cell	NULL
extracts	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

None	NULL
Act-D	NULL
Emet	NULL
CsA	NULL
E	NULL
EA	NULL
-	NULL
E	NULL
EA	NULL
-	NULL
E	NULL
EA	NULL
Stimulus	NULL
-	NULL
E	NULL
BA	NULL
NFATe	NULL
f	NULL
¬´	NULL
|	NULL
-ass	NULL
-	NULL
188	NULL
iy	NULL
8m	NULL
¬´	NULL
¬ª	NULL
#	NULL
8800	NULL
Figure	NULL
9	NULL
.	NULL

-	NULL
Expression	NULL
of	NULL
NFATe	NULL
mRNA	NULL
in	NULL
CD16-stimulated	NULL
NK	NULL
cells	NULL
.	NULL

NK	NULL
cells	NULL
,	NULL
4	NULL
x	NULL
10	NULL
``	NULL
per	NULL
sample	NULL
,	NULL
were	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
in	NULL
medium	NULL
without	NULL
(	NULL
None	NULL
)	NULL
or	NULL
with	NULL
Act	NULL
D	NULL
,	NULL
emetine	NULL
,	NULL
and	NULL
CsA	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Medium	NULL
(	NULL
-	NULL
)	NULL
,	NULL
E	NULL
,	NULL
or	NULL
EA	NULL
was	NULL
added	NULL
to	NULL
identical	NULL
107	NULL
cell	NULL
aliquots	NULL
of	NULL
the	NULL
samples	NULL
and	NULL
incubation	NULL
was	NULL
continued	NULL
for	NULL
2	NULL
h.	NULL
Total	NULL
RNA	NULL
was	NULL
then	NULL
ex-tracted	NULL
,	NULL
run	NULL
in	NULL
1	NULL
%	NULL
agarose	NULL
denaturing	NULL
gel	NULL
,	NULL
and	NULL
Northern	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
a	NULL
human	NULL
NFATe	NULL
random	NULL
primer-labeled	NULL
cDNA	NULL
probe	NULL
(	NULL
top	NULL
panel	NULL
)	NULL
.	NULL

After	NULL
stripping	NULL
,	NULL
the	NULL
same	NULL
blot	NULL
was	NULL
hybridized	NULL
to	NULL
the	NULL
32M	NULL
cDNA	NULL
(	NULL
bottom	NULL
panel	NULL
)	NULL
to	NULL
control	NULL
amounts	NULL
of	NULL
RNA	NULL
loaded	NULL
per	NULL
lane	NULL
.	NULL

Positions	NULL
of	NULL
18	NULL
and	NULL
28	NULL
S	NULL
mRNA	NULL
are	NULL
indicated	NULL
.	NULL

Discussion	NULL
The	NULL
results	NULL
presented	NULL
here	NULL
demonstrate	NULL
that	NULL
NFAT	NULL
is	NULL
expressed	NULL
in	NULL
NK	NULL
cells	NULL
.	NULL

Stimulation	NULL
of	NULL
these	NULL
cells	NULL
with	NULL
immune	NULL
complexes	NULL
not	NULL
only	NULL
results	NULL
in	NULL
activation	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
a	NULL
preexisting	NULL
cytoplasmic	NULL
NFATp	NULL
component	NULL
identical	NULL
to	NULL
that	NULL
present	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
but	NULL
also	NULL
induces	NULL
de	NULL
novo	NULL
expression	NULL
of	NULL
NFATe	NULL
mRNA	NULL
,	NULL
and	NULL
the	NULL
former	NULL
NFAT	NULL
is	NULL
functionally	NULL
active	NULL
in	NULL
regulating	NULL
cytokine	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
use	NULL
of	NULL
homogeneous	NULL
NK	NULL
cell	NULL
preparations	NULL
with	NULL
no	NULL
detectable	NULL
T	NULL
cell	NULL
contaminants	NULL
and	NULL
of	NULL
stimuli	NULL
that	NULL
do	NULL
not	NULL
activate	NULL
T	NULL
lymphocytes	NULL
(	NULL
10	NULL
)	NULL
exclude	NULL
the	NULL
participation	NULL
of	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
observed	NULL
effects	NULL
.	NULL

FcyRIIIA	NULL
ligands	NULL
and	NULL
cytokines	NULL
,	NULL
e.g	NULL
.	NULL

,	NULL
IL-2	NULL
and	NULL
IL-12	NULL
,	NULL
induce	NULL
transcription	NULL
of	NULL
cytokine	NULL
genes	NULL
in	NULL
NK	NULL
cells	NULL
.	NULL

The	NULL
IL-2-and	NULL
IIL-12-induced	NULL
transcription	NULL
is	NULL
Ca**	NULL
independent	NULL
(	NULL
8	NULL
)	NULL
;	NULL
that	NULL
induced	NULL
upon	NULL
FeyR	NULL
stimulation	NULL
is	NULL
Ca*+*	NULL
dependent	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
demonstrate	NULL
that	NULL
TNF	NULL
and	NULL
GM-CSF	NULL
(	NULL
like	NULL
IFN-y	NULL
and	NULL
c-myc	NULL
,	NULL
not	NULL
shown	NULL
)	NULL
expression	NULL
is	NULL
induced	NULL
upon	NULL
CD16	NULL
stimulation	NULL
in	NULL
a	NULL
CsA-sensitive	NULL
fashion	NULL
,	NULL
independent	NULL
of	NULL
protein	NULL
synthesis	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
effect	NULL
of	NULL
both	NULL
CD16	NULL
stimulation	NULL
and	NULL
CsA	NULL
occur	NULL
at	NULL
the	NULL
level	NULL
of	NULL
preexisting	NULL
elements	NULL
in	NULL
NK	NULL
cells	NULL
.	NULL

These	NULL
data	NULL
add	NULL
to	NULL
previous	NULL
observations	NULL
indicating	NULL
a	NULL
similarity	NULL
at	NULL
the	NULL
molecular	NULL
and	NULL
signal	NULL
transduction	NULL
levels	NULL
between	NULL
CD16	NULL
and	NULL
the	NULL
TCR	NULL
and	NULL
slg	NULL
complexes	NULL
on	NULL
T	NULL
and	NULL
B	NULL
lymphocytes	NULL
(	NULL
38	NULL
,	NULL
39	NULL
)	NULL
,	NULL
where	NULL
the	NULL
Ca**-dependent	NULL
,	NULL
CsA-sensitive	NULL
factor	NULL
NFAT	NULL
is	NULL
involved	NULL
in	NULL
antigen	NULL
receptor-mediated	NULL
gene	NULL
transcription	NULL
.	NULL

In	NULL
T	NULL
cells	NULL
NFAT	NULL
regulates	NULL
transcription	NULL
of	NULL
IL-2	NULL
,	NULL
IL-3	NULL
,	NULL
IL-4	NULL
,	NULL
GM-CSF	NULL
,	NULL
and	NULL
TNF	NULL
genes	NULL
(	NULL
11	NULL
,	NULL
16	NULL
,	NULL
17	NULL
,	NULL
19	NULL
,	NULL
20	NULL
,	NULL
40	NULL
)	NULL
.	NULL

Among	NULL
these	NULL
genes	NULL
,	NULL
at	NULL
least	NULL
TNF	NULL
appears	NULL
to	NULL
be	NULL
similarly	NULL
regulated	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
where	NULL
NFAT	NULL
is	NULL
transcriptionally	NULL
active	NULL
(	NULL
26-28	NULL
,	NULL
41	NULL
)	NULL
.	NULL

In	NULL
NK	NULL
cells	NULL
,	NULL
ligation	NULL
of	NULL
FeyRIII	NULL
with	NULL
specific	NULL
mAb	NULL
or	NULL
Ag-Ab	NULL
complexes	NULL
,	NULL
its	NULL
physiologic	NULL
ligand	NULL
,	NULL
activates	NULL
a	NULL
nuclear	NULL
factor	NULL
that	NULL
has	NULL
the	NULL
same	NULL
DNA	NULL
binding	NULL
specificity	NULL
as	NULL
NFAT	NULL
,	NULL
this	NULL
activation	NULL
,	NULL
like	NULL
that	NULL
of	NULL
the	NULL
CD16-induced	NULL
cytokines	NULL
,	NULL
is	NULL
CsA	NULL
sensitive	NULL
and	NULL
Ca**	NULL
dependent	NULL
.	NULL

Instead	NULL
,	NULL
Ca**-indepen-dent	NULL
signals	NULL
transduced	NULL
by	NULL
cytokines	NULL
(	NULL
IL-2	NULL
)	NULL
that	NULL
induce	NULL
TNF	NULL
and	NULL
GM-CSF	NULL
expression	NULL
do	NULL
not	NULL
mediate	NULL
NFAT	NULL
activation	NULL
807	NULL
Aramburu	NULL
et	NULL
al	NULL
.	NULL

(	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
CD16	NULL
specifically	NULL
engages	NULL
Ca*+*-dependent	NULL
,	NULL
CsA-sensitive	NULL
elements	NULL
.	NULL

Nuclear	NULL
extracts	NULL
of	NULL
CD16-stimulated	NULL
NK	NULL
cells	NULL
contain	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
that	NULL
bind	NULL
specifically	NULL
NFAT	NULL
binding	NULL
sequences	NULL
present	NULL
in	NULL
the	NULL
enhancer	NULL
regions	NULL
of	NULL
the	NULL
promoters	NULL
of	NULL
several	NULL
cytokines	NULL
produced	NULL
by	NULL
NK	NULL
cells	NULL
,	NULL
eg	NULL
.	NULL

,	NULL
TNF	NULL
,	NULL
GM-CSF	NULL
,	NULL
and	NULL
IL-3	NULL
(	NULL
16	NULL
,	NULL
17	NULL
,	NULL
19	NULL
)	NULL
,	NULL
and	NULL
these	NULL
same	NULL
sequences	NULL
compete	NULL
specifically	NULL
,	NULL
and	NULL
as	NULL
efficiently	NULL
as	NULL
those	NULL
contained	NULL
in	NULL
the	NULL
IL-2	NULL
and	NULL
IL-4	NULL
promoters	NULL
,	NULL
for	NULL
NFAT	NULL
binding	NULL
to	NULL
the	NULL
distal	NULL
NFAT	NULL
IL-2	NULL
binding	NULL
site	NULL
present	NULL
in	NULL
the	NULL
oligonucleotides	NULL
used	NULL
in	NULL
the	NULL
EMSA	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
NK	NULL
cell	NULL
NFAT	NULL
has	NULL
DNA	NULL
binding	NULL
specificity	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
its	NULL
T	NULL
and	NULL
B	NULL
cell	NULL
counterparts	NULL
(	NULL
11	NULL
,	NULL
26	NULL
,	NULL
27	NULL
,	NULL
42	NULL
)	NULL
,	NULL
and	NULL
it	NULL
supports	NULL
a	NULL
critical	NULL
role	NULL
for	NULL
NFAT	NULL
in	NULL
NK	NULL
cell	NULL
transcriptional	NULL
regulation	NULL
of	NULL
these	NULL
cytokines	NULL
.	NULL

The	NULL
same	NULL
data	NULL
,	NULL
however	NULL
,	NULL
do	NULL
not	NULL
exclude	NULL
the	NULL
participation	NULL
of	NULL
other	NULL
as	NULL
yet	NULL
not	NULL
identified	NULL
components	NULL
in	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
cytokine	NULL
genes	NULL
in	NULL
NK	NULL
cells	NULL
,	NULL
analogous	NULL
to	NULL
the	NULL
necessary	NULL
,	NULL
but	NULL
not	NULL
sufficient	NULL
,	NULL
role	NULL
of	NULL
NFAT	NULL
in	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
43	NULL
)	NULL
.	NULL

NK	NULL
cells	NULL
NFAT	NULL
can	NULL
associate	NULL
with	NULL
AP-1	NULL
,	NULL
as	NULL
established	NULL
using	NULL
the	NULL
hull	NULL
2	NULL
NFAT	NULL
site	NULL
.	NULL

NFAT	NULL
binding	NULL
to	NULL
this	NULL
element	NULL
requires	NULL
a	NULL
nuclear	NULL
component	NULL
newly	NULL
synthesized	NULL
in	NULL
a	NULL
PKC-dependent	NULL
fashion	NULL
(	NULL
38	NULL
,	NULL
44	NULL
,	NULL
45	NULL
)	NULL
.	NULL

This	NULL
component	NULL
contains	NULL
AP-1	NULL
,	NULL
which	NULL
is	NULL
formed	NULL
by	NULL
various	NULL
combinations	NULL
of	NULL
jun	NULL
or	NULL
jun-fos	NULL
polypep-tides	NULL
(	NULL
45	NULL
,	NULL
46	NULL
)	NULL
.	NULL

NFATp-AP-1	NULL
interaction	NULL
results	NULL
in	NULL
increased	NULL
NFATp	NULL
DNA	NULL
binding	NULL
and	NULL
transcriptional	NULL
capacity	NULL
at	NULL
the	NULL
recognition	NULL
sites	NULL
in	NULL
the	NULL
IL-2	NULL
promoter	NULL
and	NULL
in	NULL
at	NULL
least	NULL
one	NULL
NFAT	NULL
site	NULL
(	NULL
CLEO	NULL
)	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
(	NULL
11	NULL
,	NULL
25	NULL
)	NULL
.	NULL

AP-1	NULL
oligonucleotides	NULL
inhibited	NULL
binding	NULL
of	NULL
NK	NULL
cell	NULL
NFATp	NULL
to	NULL
the	NULL
NFAT	NULL
hull-2	NULL
probe	NULL
,	NULL
proving	NULL
that	NULL
the	NULL
factor	NULL
can	NULL
associate	NULL
with	NULL
AP-1	NULL
.	NULL

In	NULL
the	NULL
NK	NULL
cells	NULL
used	NULL
here	NULL
,	NULL
EMSA	NULL
revealed	NULL
significant	NULL
levels	NULL
of	NULL
AP-1	NULL
activity	NULL
,	NULL
and	NULL
FeyRIII	NULL
stimulation	NULL
increased	NULL
tained	NULL
this	NULL
activity	NULL
for	NULL
prolonged	NULL
periods	NULL
of	NULL
time	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
revealed	NULL
expression	NULL
of	NULL
c-jun	NULL
and	NULL
jun-D	NULL
but	NULL
not	NULL
jun-B	NULL
or	NULL
c-fos	NULL
before	NULL
stimulation	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
complexes	NULL
containing	NULL
c-jun	NULL
and	NULL
jun-D	NULL
,	NULL
known	NULL
to	NULL
compose	NULL
AP-1	NULL
(	NULL
45	NULL
)	NULL
,	NULL
are	NULL
preformed	NULL
in	NULL
these	NULL
cells	NULL
and	NULL
contribute	NULL
to	NULL
the	NULL
constitutive	NULL
AP-1	NULL
activity	NULL
.	NULL

CD16	NULL
stimulation	NULL
also	NULL
induces	NULL
c-fos	NULL
mRNA	NULL
accumulation	NULL
within	NULL
20	NULL
min	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
which	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
sustained	NULL
AP-1	NULL
levels	NULL
observed	NULL
after	NULL
stimulation	NULL
.	NULL

Inhibition	NULL
of	NULL
AP-1	NULL
synthesis	NULL
and/or	NULL
lack	NULL
of	NULL
replacement	NULL
of	NULL
NFATp	NULL
with	NULL
newly	NULL
synthesized	NULL
protein	NULL
might	NULL
account	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
for	NULL
the	NULL
decreased	NULL
NFAT	NULL
levels	NULL
at	NULL
later	NULL
times	NULL
after	NULL
stimulation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
protein	NULL
synthesis	NULL
.	NULL

Kinetics	NULL
of	NULL
induction	NULL
of	NULL
the	NULL
AP-1-dependent	NULL
NFAT	NULL
activity	NULL
in	NULL
freshly	NULL
purified	NULL
NK	NULL
cells	NULL
,	NULL
however	NULL
,	NULL
may	NULL
not	NULL
correspond	NULL
to	NULL
that	NULL
reported	NULL
here	NULL
,	NULL
where	NULL
constitutive	NULL
AP-1	NULL
activity	NULL
likely	NULL
reflects	NULL
previous	NULL
activation	NULL
of	NULL
the	NULL
cells	NULL
in	NULL
the	NULL
culture	NULL
system	NULL
used	NULL
to	NULL
obtain	NULL
large	NULL
numbers	NULL
of	NULL
polyclonal	NULL
NK	NULL
cell	NULL
popula-tions	NULL
.	NULL

Although	NULL
phenotypically	NULL
and	NULL
functionally	NULL
equivalent	NULL
to	NULL
NK	NULL
cells	NULL
freshly	NULL
separated	NULL
from	NULL
peripheral	NULL
blood	NULL
(	NULL
31	NULL
)	NULL
,	NULL
the	NULL
short-term	NULL
cultured	NULL
NK	NULL
cells	NULL
revert	NULL
to	NULL
a	NULL
resting	NULL
state	NULL
after	NULL
activation/proliferation	NULL
in	NULL
culture	NULL
,	NULL
and	NULL
they	NULL
respond	NULL
to	NULL
several	NULL
stimuli	NULL
proliferating	NULL
and/or	NULL
producing	NULL
cytokines	NULL
with	NULL
faster	NULL
kinetics	NULL
than	NULL
resting	NULL
,	NULL
non-previously	NULL
activated	NULL
cells	NULL
(	NULL
31	NULL
,	NULL
47	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
from	NULL
nonstimulated	NULL
NK	NULL
cells	NULL
contain	NULL
NFAT	NULL
,	NULL
but	NULL
not	NULL
AP-1	NULL
or	NULL
AP-1-dependent	NULL
NFAT	NULL
activity	NULL
,	NULL
as	NULL
expected	NULL
since	NULL
AP-1	NULL
is	NULL
composed	NULL
of	NULL
nuclear	NULL
proteins	NULL
.	NULL

Absence	NULL
of	NULL
AP-1	NULL
in	NULL
these	NULL
extracts	NULL
also	NULL
serves	NULL
to	NULL
exclude	NULL
possible	NULL
artefacts	NULL
due	NULL
to	NULL
contamination	NULL
with	NULL
nuclear	NULL
material	NULL
.	NULL

NFAT	NULL
was	NULL
detected	NULL
in	NULL
cytosolic	NULL
extracts	NULL
of	NULL
NK	NULL
cells	NULL
using	NULL
the	NULL
mIl-4	NULL
NFAT	NULL
probe	NULL
,	NULL
to	NULL
which	NULL
it	NULL
can	NULL
bind	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
additional	NULL
factors	NULL
.	NULL

AP-1-dependent	NULL
NFAT	NULL
activity	NULL
detected	NULL
with	NULL
the	NULL
hull	NULL
2	NULL
probe	NULL
was	NULL
reconstituted	NULL
when	NULL
nuclear	NULL
extracts	NULL
from	NULL
nonstimulated	NULL
cells	NULL
containing	NULL
no	NULL
NFAT	NULL
activity	NULL
but	NULL
expressing	NULL
AP-1	NULL
were	NULL
combined	NULL
with	NULL
cytoplasmic	NULL
preparations	NULL
from	NULL
the	NULL
same	NULL
cells	NULL
,	NULL
indicating	NULL
association	NULL
of	NULL
cytoplasmic	NULL
NFAT	NULL
with	NULL
nuclear	NULL
AP-1	NULL
,	NULL
and	NULL
supporting	NULL
the	NULL
hypothesis	NULL
that	NULL
NFAT	NULL
activation	NULL
in	NULL
NK	NULL
cells	NULL
results	NULL
in	NULL
its	NULL
translocation	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
as	NULL
reported	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
cytoplasmic	NULL
NFATp	NULL
is	NULL
preexistent	NULL
in	NULL
NK	NULL
cells	NULL
,	NULL
as	NULL
confirmed	NULL
by	NULL
its	NULL
identification	NULL
in	NULL
nonstimulated	NULL
cells	NULL
as	NULL
a	NULL
protein	NULL
with	NULL
antigenic	NULL
and	NULL
biochemical	NULL
characteristics	NULL
indistinguishable	NULL
from	NULL
those	NULL
of	NULL
the	NULL
cytoplasmic	NULL
,	NULL
phosphorylated	NULL
form	NULL
of	NULL
NFATp	NULL
(	NULL
35	NULL
)	NULL
.	NULL

NFATp	NULL
belongs	NULL
to	NULL
a	NULL
family	NULL
of	NULL
factors	NULL
that	NULL
include	NULL
NFATe	NULL
(	NULL
30	NULL
)	NULL
and	NULL
the	NULL
recently	NULL
cloned	NULL
NFATx	NULL
(	NULL
47	NULL
)	NULL
,	NULL
all	NULL
sharing	NULL
significant	NULL
homology	NULL
,	NULL
identical	NULL
DNA	NULL
binding	NULL
specificity	NULL
,	NULL
and	NULL
capable	NULL
of	NULL
associating	NULL
with	NULL
AP-1	NULL
(	NULL
29	NULL
,	NULL
30	NULL
,	NULL
47	NULL
)	NULL
.	NULL

NFATx	NULL
mRNA	NULL
is	NULL
expressed	NULL
preferentially	NULL
in	NULL
the	NULL
thymus	NULL
and	NULL
at	NULL
very	NULL
low	NULL
levels	NULL
in	NULL
peripheral	NULL
leukocytes	NULL
.	NULL

NFATe	NULL
expression	NULL
is	NULL
inducible	NULL
by	NULL
PKC	NULL
activators	NULL
in	NULL
human	NULL
T	NULL
cell	NULL
lines	NULL
,	NULL
as	NULL
well	NULL
as	NULL
splenic	NULL
and	NULL
thymic	NULL
cells	NULL
(	NULL
30	NULL
)	NULL
.	NULL

NFATe	NULL
mRNA	NULL
is	NULL
undetectable	NULL
in	NULL
nonstimulated	NULL
NK	NULL
cells	NULL
,	NULL
but	NULL
is	NULL
induced	NULL
in	NULL
a	NULL
CsA-sensitive	NULL
fashion	NULL
after	NULL
a	NULL
2-h	NULL
stimulation	NULL
with	NULL
FeyR	NULL
ligands	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
or	NULL
phorbol	NULL
esters	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
for	NULL
primary	NULL
NK	NULL
cells	NULL
extend	NULL
results	NULL
reported	NULL
using	NULL
T	NULL
cell	NULL
lines	NULL
.	NULL

Expression	NULL
of	NULL
NFATe	NULL
mRNA	NULL
is	NULL
detectable	NULL
in	NULL
emetine-treated	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
de	NULL
novo	NULL
RNA	NULL
synthesis	NULL
,	NULL
suggesting	NULL
that	NULL
CD16-induced	NULL
NFAT	NULL
expression	NULL
occurs	NULL
via	NULL
a	NULL
mechanism	NULL
that	NULL
includes	NULL
direct	NULL
or	NULL
indirect	NULL
induction	NULL
of	NULL
gene	NULL
transcription	NULL
,	NULL
independent	NULL
from	NULL
newly	NULL
synthesized	NULL
proteins	NULL
.	NULL

Despite	NULL
the	NULL
fact	NULL
that	NULL
NFATe	NULL
mRNA	NULL
was	NULL
inducible	NULL
in	NULL
NK	NULL
cells	NULL
,	NULL
we	NULL
did	NULL
not	NULL
detect	NULL
NFATe	NULL
protein	NULL
,	NULL
and	NULL
the	NULL
NFATe-specific	NULL
mAb	NULL
did	NULL
not	NULL
induce	NULL
supershift	NULL
in	NULL
nuclear	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
or	NULL
cytosolic	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
extracts	NULL
from	NULL
1-h	NULL
stimulated	NULL
NK	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
the	NULL
same	NULL
mAb	NULL
supershifted	NULL
the	NULL
NFAT	NULL
detected	NULL
in	NULL
the	NULL
Jurkat	NULL
cell	NULL
line	NULL
and	NULL
in	NULL
phorbol	NULL
ester-	NULL
and	NULL
ionomycin-stimulated	NULL
PHA	NULL
lymphoblasts	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
where	NULL
the	NULL
combination	NULL
of	NULL
both	NULL
anti-NFATp	NULL
and	NULL
anti-NFATe	NULL
antibodies	NULL
supershifted	NULL
virtually	NULL
all	NULL
the	NULL
complex	NULL
.	NULL

Several	NULL
possibilities	NULL
may	NULL
account	NULL
for	NULL
the	NULL
inability	NULL
of	NULL
the	NULL
anti-NFATe	NULL
mAb	NULL
to	NULL
detect	NULL
this	NULL
molecule	NULL
in	NULL
NK	NULL
cells	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
observations	NULL
that	NULL
NFATe	NULL
isoforms	NULL
exist	NULL
(	NULL
Crabtree	NULL
,	NULL
G.	NULL
,	NULL
personal	NULL
communication	NULL
)	NULL
and	NULL
may	NULL
be	NULL
differentially	NULL
expressed	NULL
in	NULL
distinct	NULL
hematopoietic	NULL
cell	NULL
lineages	NULL
,	NULL
and	NULL
that	NULL
the	NULL
supershift	NULL
induced	NULL
by	NULL
the	NULL
anti-	NULL
NFATp	NULL
antibodies	NULL
is	NULL
incomplete	NULL
,	NULL
the	NULL
most	NULL
likely	NULL
explanation	NULL
for	NULL
these	NULL
results	NULL
is	NULL
that	NULL
an	NULL
NFATe	NULL
isoform	NULL
or	NULL
NFAT	NULL
species	NULL
different	NULL
from	NULL
that	NULL
detected	NULL
by	NULL
the	NULL
mAb	NULL
used	NULL
here	NULL
is/are	NULL
expressed	NULL
in	NULL
NK	NULL
cells	NULL
.	NULL

Other	NULL
possibilities	NULL
include	NULL
that	NULL
the	NULL
epitope	NULL
detected	NULL
by	NULL
the	NULL
antibody	NULL
is	NULL
masked	NULL
by	NULL
a	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
absent	NULL
in	NULL
T	NULL
cells	NULL
but	NULL
present	NULL
in	NULL
NK	NULL
cells	NULL
,	NULL
or	NULL
that	NULL
the	NULL
NFATe	NULL
mRNA	NULL
transcript	NULL
induced	NULL
in	NULL
NK	NULL
cells	NULL
is	NULL
nonproductive	NULL
.	NULL

However	NULL
,	NULL
both	NULL
possibilities	NULL
are	NULL
unlikely	NULL
because	NULL
(	NULL
a	NULL
)	NULL
the	NULL
anti-NFATe	NULL
mAb	NULL
supershifted	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
NFAT	NULL
in	NULL
Jurkat	NULL
cell	NULL
extracts	NULL
when	NULL
tested	NULL
either	NULL
separately	NULL
or	NULL
mixed	NULL
with	NULL
an	NULL
excess	NULL
nuclear	NULL
extract	NULL
from	NULL
CD16-stimulated	NULL
NK	NULL
cells	NULL
,	NULL
where	NULL
NFATe	NULL
was	NULL
undetectable	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
;	NULL
and	NULL
(	NULL
b	NULL
)	NULL
the	NULL
size	NULL
of	NULL
the	NULL
NFATe	NULL
mRNA	NULL
in	NULL
NK	NULL
cells	NULL
is	NULL
identical	NULL
to	NULL
that	NULL
in	NULL
T	NULL
lymphocytes	NULL
and	NULL
corresponds	NULL
to	NULL
that	NULL
reported	NULL
for	NULL
a	NULL
productive	NULL
transcript	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
indicate	NULL
that	NULL
NFATp	NULL
is	NULL
the	NULL
most	NULL
relevant	NULL
,	NULL
if	NULL
not	NULL
the	NULL
only	NULL
,	NULL
protein	NULL
included	NULL
in	NULL
the	NULL
NFAT	NULL
complexes	NULL
detected	NULL
in	NULL
NK	NULL
cells	NULL
at	NULL
early	NULL
times	NULL
after	NULL
CD16	NULL
stimulation	NULL
.	NULL

The	NULL
relative	NULL
amount	NULL
of	NULL
NFATp	NULL
supershifted	NULL
varied	NULL
(	NULL
60-90	NULL
%	NULL
)	NULL
in	NULL
experiments	NULL
repeated	NULL
with	NULL
individual	NULL
nuclear	NULL
extracts	NULL
,	NULL
suggesting	NULL
that	NULL
interexperimental	NULL
variability	NULL
may	NULL
account	NULL
,	NULL
in	NULL
part	NULL
,	NULL
for	NULL
the	NULL
incomplete	NULL
supershift	NULL
.	NULL

However	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
residual	NULL
NFAT	NULL
not	NULL
supershifted	NULL
by	NULL
the	NULL
available	NULL
anti-NFATp	NULL
and	NULL
-NFATe	NULL
antibodies	NULL
may	NULL
reflect	NULL
the	NULL
participation	NULL
of	NULL
additional	NULL
factors	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
NFATx	NULL
or	NULL
new	NULL
family	NULL
members	NULL
)	NULL
with	NULL
DNA	NULL
binding	NULL
specificity	NULL
overlapping	NULL
with	NULL
that	NULL
of	NULL
NFATp	NULL
.	NULL

Our	NULL
data	NULL
support	NULL
the	NULL
conclusion	NULL
that	NULL
CD16	NULL
stimulation	NULL
in	NULL
NK	NULL
cells	NULL
induces	NULL
NFATp	NULL
activation	NULL
that	NULL
likely	NULL
promotes	NULL
,	NULL
in	NULL
a	NULL
CsA-sensitive	NULL
and	NULL
possibly	NULL
calcineurin	NULL
A-dependent	NULL
fashion	NULL
,	NULL
translocation	NULL
to	NULL
the	NULL
nucleus	NULL
of	NULL
a	NULL
preexistent	NULL
NFATp	NULL
,	NULL
identical	NULL
to	NULL
that	NULL
predominant	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
although	NULL
formal	NULL
proof	NULL
of	NULL
the	NULL
latter	NULL
awaits	NULL
nucleotide	NULL
sequence	NULL
comparison	NULL
.	NULL

They	NULL
confirm	NULL
that	NULL
the	NULL
NFATp	NULL
cytoplasmic	NULL
component	NULL
is	NULL
not	NULL
specifically	NULL
and	NULL
exclusively	NULL
expressed	NULL
in	NULL
T	NULL
lymphocytes	NULL
,	NULL
and	NULL
they	NULL
serve	NULL
to	NULL
further	NULL
generalize	NULL
this	NULL
conclusion	NULL
to	NULL
all	NULL
lym-phoid	NULL
and	NULL
,	NULL
possibly	NULL
,	NULL
most	NULL
hematopoietic	NULL
cell	NULL
types	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
it	NULL
will	NULL
be	NULL
interesting	NULL
to	NULL
determine	NULL
whether	NULL
Ab-independent	NULL
target	NULL
cell	NULL
recognition	NULL
by	NULL
NK	NULL
cells	NULL
,	NULL
which	NULL
results	NULL
in	NULL
Ca**+-dependent	NULL
activation	NULL
of	NULL
cytokine	NULL
genes	NULL
via	NULL
a	NULL
mechanism	NULL
at	NULL
least	NULL
in	NULL
part	NULL
distinct	NULL
from	NULL
that	NULL
induced	NULL
via	NULL
FeyRIIIA	NULL
(	NULL
49	NULL
,	NULL
50	NULL
)	NULL
,	NULL
can	NULL
activate	NULL
NFATp	NULL
,	NULL
and	NULL
which	NULL
physiologic	NULL
stimuli	NULL
are	NULL
involved	NULL
in	NULL
NFAT	NULL
activation	NULL
in	NULL
antigen-presenting	NULL
cells	NULL
,	NULL
e.	NULL
g.	NULL
,	NULL
monocytes	NULL
(	NULL
11	NULL
)	NULL
.	NULL

The	NULL
significance	NULL
of	NULL
NFATe	NULL
mRNA	NULL
induction	NULL
in	NULL
NK	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
possibility	NULL
that	NULL
new	NULL
species	NULL
of	NULL
the	NULL
NFAT	NULL
family	NULL
are	NULL
expressed	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
awaits	NULL
further	NULL
study	NULL
.	NULL

Generation	NULL
of	NULL
additional	NULL
antibodies	NULL
to	NULL
NFATp	NULL
and	NULL
NFAT	NULL
isoforms	NULL
and/or	NULL
,	NULL
possibly	NULL
,	NULL
other	NULL
NFAT	NULL
species	NULL
will	NULL
help	NULL
to	NULL
address	NULL
the	NULL
question	NULL
of	NULL
the	NULL
relative	NULL
contribution	NULL
of	NULL
NFAT	NULL
members	NULL
to	NULL
gene	NULL
expression	NULL
,	NULL
not	NULL
only	NULL
in	NULL
NK	NULL
cells	NULL
,	NULL
but	NULL
also	NULL
in	NULL
other	NULL
immune	NULL
cell	NULL
types	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
Dr.	NULL
G.	NULL
Crabtree	NULL
for	NULL
providing	NULL
the	NULL
NFATe	NULL
cDNA	NULL
and	NULL
anti-NFATe	NULL
mAb	NULL
and	NULL
for	NULL
helpful	NULL
discussions	NULL
,	NULL
Tatiana	NULL
Mikheeva	NULL
for	NULL
technical	NULL
assistance	NULL
,	NULL
and	NULL
Marina	NULL
Hoffman	NULL
for	NULL
editing	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
U.S.	NULL
Public	NULL
Health	NULL
Service	NULL
grants	NULL
CA37155	NULL
and	NULL
CA45284	NULL
.	NULL

J.	NULL
Aramburu	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
a	NULL
postdoctoral	NULL
fellowship	NULL
from	NULL
the	NULL
Ministerio	NULL
de	NULL
Educacion	NULL
y	NULL
Ciencia	NULL
of	NULL
Spain	NULL
.	NULL

808	NULL
NFAT	NULL
Activation	NULL
in	NULL
NK	NULL
Cells	NULL
Address	NULL
correspondence	NULL
to	NULL
Bice	NULL
Perussia	NULL
,	NULL
Thomas	NULL
Jefferson	NULL
University	NULL
,	NULL
Jefferson	NULL
Cancer	NULL
Institute	NULL
,	NULL
BLSB	NULL
Room	NULL
750	NULL
,	NULL
233	NULL
South	NULL
10th	NULL
Street	NULL
,	NULL
Philadelphia	NULL
,	NULL
PA	NULL
19107	NULL
.	NULL

The	NULL
current	NULL
address	NULL
for	NULL
Jos√©	NULL
Aramburu	NULL
is	NULL
Division	NULL
of	NULL
Cellular	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Dana	NULL
Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
44	NULL
Binney	NULL
Street	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02134	NULL
.	NULL

Received	NULL
for	NULL
publication	NULL
20	NULL
December	NULL
1994	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
1	NULL
May	NULL
1995	NULL
.	NULL

References	NULL
1	NULL
.	NULL

2	NULL
.	NULL

3	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

Trinchieri	NULL
,	NULL
G.	NULL
1989	NULL
.	NULL

Biology	NULL
of	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

Adv	NULL
.	NULL

Immunol	NULL
.	NULL

47:187-376	NULL
.	NULL

Perussia	NULL
,	NULL
B	NULL
.	NULL

1991	NULL
.	NULL

Lymphokine	NULL
activated	NULL
killer	NULL
cells	NULL
,	NULL
natural	NULL
killer	NULL
cells	NULL
,	NULL
and	NULL
cytokines	NULL
.	NULL

Curr	NULL
Opin	NULL
.	NULL

Immunol	NULL
.	NULL

3:49-55	NULL
.	NULL

Moretta	NULL
,	NULL
L.	NULL
,	NULL
E.	NULL
Ciccone	NULL
,	NULL
M.C	NULL
.	NULL

Mingari	NULL
,	NULL
R.	NULL
Biassoni	NULL
,	NULL
and	NULL
A.	NULL
Moretta	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
natural	NULL
killer	NULL
cells	NULL
:	NULL
origin	NULL
,	NULL
clonality	NULL
,	NULL
specificity	NULL
and	NULL
receptors	NULL
.	NULL

Adv	NULL
.	NULL

Immunol	NULL
.	NULL

55:341-380.	NULL
.	NULL

Vivier	NULL
,	NULL
E.	NULL
,	NULL
P.	NULL
Morin	NULL
,	NULL
C.	NULL
O'Brien	NULL
,	NULL
B.	NULL
Druker	NULL
,	NULL
S.F	NULL
.	NULL

Schlossman	NULL
,	NULL
and	NULL
P.	NULL
Anderson	NULL
.	NULL

1991	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
FcyRIII	NULL
(	NULL
CD16	NULL
)	NULL
is	NULL
mediated	NULL
through	NULL
the	NULL
y	NULL
chain	NULL
.	NULL

J.	NULL
Exp	NULL
Med	NULL
.	NULL

175:1381-1390.	NULL
.	NULL

Kanakaraj	NULL
,	NULL
P.	NULL
,	NULL
B.	NULL
Duckworth	NULL
,	NULL
L.	NULL
Azzoni	NULL
,	NULL
M.	NULL
Kamoun	NULL
,	NULL
LC	NULL
.	NULL

Cantley	NULL
,	NULL
and	NULL
B.	NULL
Perussia	NULL
.	NULL

1994	NULL
.	NULL

Phosphatidylinositol-3	NULL
kinase	NULL
activation	NULL
induced	NULL
upon	NULL
FeyRIIIA-ligand	NULL
interaction	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

179:551-558.	NULL
.	NULL

Bonnema	NULL
,	NULL
J.D	NULL
.	NULL

,	NULL
L.M	NULL
.	NULL

Karnitz	NULL
,	NULL
R.A.	NULL
Schoon	NULL
,	NULL
RT	NULL
.	NULL

Abraham	NULL
,	NULL
and	NULL
P.J	NULL
.	NULL

Leibson	NULL
.	NULL

1994	NULL
.	NULL

Fc	NULL
receptor	NULL
stimulation	NULL
of	NULL
phosphati-dylinositol	NULL
3-kinase	NULL
in	NULL
natural	NULL
killer	NULL
cells	NULL
is	NULL
associated	NULL
with	NULL
protein	NULL
kinase	NULL
C-independent	NULL
granule	NULL
release	NULL
and	NULL
cell-mediated	NULL
cytotoxicity	NULL
.	NULL

J.	NULL
Exp	NULL
Med	NULL
.	NULL

180:1427-1435.	NULL
.	NULL

Azzoni	NULL
,	NULL
L.	NULL
,	NULL
M.	NULL
Kamoun	NULL
,	NULL
TW	NULL
.	NULL

Salcedo	NULL
,	NULL
P.	NULL
Kanakaraj	NULL
,	NULL
and	NULL
B.	NULL
Perussia	NULL
.	NULL

1992	NULL
.	NULL

Stimulation	NULL
of	NULL
FeyRIIIA	NULL
results	NULL
in	NULL
phospholi-pase	NULL
C-y1	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
p56**	NULL
activation	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

176:1745-1750.	NULL
.	NULL

Cassatella	NULL
,	NULL
M.A	NULL
.	NULL

,	NULL
I.	NULL
Anegon	NULL
,	NULL
M.C	NULL
.	NULL

Cuturi	NULL
,	NULL
P.	NULL
Griskey	NULL
,	NULL
G.	NULL
Trin-	NULL
chieri	NULL
,	NULL
and	NULL
B.	NULL
Perussia	NULL
.	NULL

1989	NULL
.	NULL

FeyR	NULL
(	NULL
CD16	NULL
)	NULL
interaction	NULL
with	NULL
ligand	NULL
induces	NULL
Ca*+*	NULL
mobilization	NULL
and	NULL
phosphoinositide	NULL
turnover	NULL
in	NULL
human	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

Role	NULL
of	NULL
Ca	NULL
#	NULL
*	NULL
in	NULL
FoyR-	NULL
(	NULL
CD16	NULL
)	NULL
-induced	NULL
transcription	NULL
and	NULL
expression	NULL
of	NULL
lymphokine	NULL
genes	NULL
.	NULL

J.	NULL
Exp	NULL
Med	NULL
.	NULL

169:549-567.	NULL
.	NULL

Anegon	NULL
,	NULL
I.	NULL
,	NULL
M.	NULL
C.	NULL
Cuturi	NULL
,	NULL
G.	NULL
Trinchieri	NULL
,	NULL
and	NULL
B.	NULL
Perussia	NULL
.	NULL

1988	NULL
.	NULL

Interaction	NULL
of	NULL
Fey	NULL
receptor	NULL
(	NULL
CD16	NULL
)	NULL
with	NULL
ligands	NULL
induces	NULL
transcription	NULL
of	NULL
the	NULL
interleukin	NULL
2	NULL
receptor	NULL
(	NULL
CD25	NULL
)	NULL
and	NULL
lymphokine	NULL
genes	NULL
and	NULL
expression	NULL
of	NULL
their	NULL
products	NULL
in	NULL
human	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
Med	NULL
.	NULL

167:452-472	NULL
.	NULL

Salcedo	NULL
,	NULL
TW	NULL
.	NULL

,	NULL
L.	NULL
Azzoni	NULL
,	NULL
S.F	NULL
.	NULL

Wolf	NULL
,	NULL
and	NULL
B.	NULL
Perussia	NULL
.	NULL

1993	NULL
.	NULL

Modulation	NULL
of	NULL
perforin	NULL
and	NULL
granzymes	NULL
messenger	NULL
RNA	NULL
expression	NULL
in	NULL
human	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151:2511-2520	NULL
.	NULL

Rao	NULL
,	NULL
A	NULL
.	NULL

1994	NULL
.	NULL

NF-ATp	NULL
:	NULL
a	NULL
transcription	NULL
factor	NULL
required	NULL
for	NULL
the	NULL
co-ordinate	NULL
induction	NULL
of	NULL
several	NULL
cytokine	NULL
genes	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
.	NULL

15:274-281	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
McCaffrey	NULL
,	NULL
Z	NULL
.	NULL

Miner	NULL
,	NULL
TK	NULL
.	NULL

Kerppola	NULL
,	NULL
J.N	NULL
.	NULL

Lambert	NULL
,	NULL
G.L	NULL
.	NULL

Verdine	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
T-cell	NULL
transcription	NULL
factor	NULL
NFATp	NULL
is	NULL
a	NULL
substrate	NULL
for	NULL
calcineurin	NULL
and	NULL
interacts	NULL
with	NULL
Fos	NULL
and	NULL
Jun	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

365:352-355	NULL
.	NULL

McCaffrey	NULL
,	NULL
PG	NULL
.	NULL

,	NULL
B.A	NULL
.	NULL

Perrino	NULL
,	NULL
T.R	NULL
.	NULL

Soderling	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1993	NULL
.	NULL

NF-ATp	NULL
,	NULL
a	NULL
T	NULL
lymphocyte	NULL
DNA-binding	NULL
protein	NULL
that	NULL
is	NULL
a	NULL
target	NULL
for	NULL
calcineurin	NULL
and	NULL
immunosuppressive	NULL
drugs	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:3747-3752	NULL
.	NULL

Flanagan	NULL
,	NULL
W.M	NULL
.	NULL

,	NULL
B.	NULL
Corthsy	NULL
,	NULL
R.J.	NULL
Bram	NULL
,	NULL
and	NULL
G.R	NULL
.	NULL

Crabtree	NULL
.	NULL

1991	NULL
.	NULL

Nuclear	NULL
association	NULL
of	NULL
T-cell	NULL
transcription	NULL
factor	NULL
blocked	NULL
by	NULL
FK-506	NULL
and	NULL
cyclosporin	NULL
A	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

352:803-807	NULL
.	NULL

Clipstone	NULL
,	NULL
N.A	NULL
.	NULL

,	NULL
and	NULL
G.R	NULL
.	NULL

Crabtree	NULL
.	NULL

1992	NULL
.	NULL

Identification	NULL
of	NULL
809	NULL
Aramburu	NULL
et	NULL
al	NULL
.	NULL

calcinuerin	NULL
as	NULL
a	NULL
key	NULL
signalling	NULL
enzyme	NULL
in	NULL
T-lymphocyte	NULL
activation	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

357:695-697	NULL
.	NULL

16	NULL
.	NULL

Tsuboi	NULL
,	NULL
A.	NULL
,	NULL
E.S	NULL
.	NULL

Masuda	NULL
,	NULL
Y.	NULL
Naito	NULL
,	NULL
H.	NULL
Tokumitsu	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1994	NULL
.	NULL

Calcineurin	NULL
potentiates	NULL
activation	NULL
of	NULL
the	NULL
granulocyte	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
gene	NULL
in	NULL
T	NULL
cells	NULL
:	NULL
involvement	NULL
of	NULL
the	NULL
conserved	NULL
lymphokine	NULL
element	NULL
0	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Cell	NULL
.	NULL

5:119-128	NULL
.	NULL

17	NULL
.	NULL

Cockerill	NULL
,	NULL
PN	NULL
.	NULL

,	NULL
M.F	NULL
.	NULL

Shannon	NULL
,	NULL
A.G.	NULL
Bert	NULL
,	NULL
G.P	NULL
.	NULL

Ryan	NULL
,	NULL
and	NULL
M.A	NULL
.	NULL

Vadas	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor/interleukin	NULL
3	NULL
locus	NULL
is	NULL
regulated	NULL
by	NULL
an	NULL
inducible	NULL
cyclosporin	NULL
A-sensitive	NULL
enhancer	NULL
,	NULL
Proc	NULL
Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

90:2466-2470	NULL
.	NULL

18	NULL
.	NULL

Masuda	NULL
,	NULL
E.S	NULL
.	NULL

,	NULL
H.	NULL
Tokumitsu	NULL
,	NULL
A.	NULL
Tsuboi	NULL
,	NULL
J.	NULL
Shlomai	NULL
,	NULL
P.	NULL
Hung	NULL
,	NULL
K.	NULL
I.	NULL
Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
promoter	NULL
cis-acting	NULL
element	NULL
CLEO	NULL
mediates	NULL
induction	NULL
signals	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
is	NULL
recognized	NULL
by	NULL
factors	NULL
related	NULL
to	NULL
AP1	NULL
and	NULL
NFAT	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:7399-7407	NULL
.	NULL

19	NULL
.	NULL

Goldfeld	NULL
,	NULL
A.E	NULL
.	NULL

,	NULL
PG	NULL
.	NULL

McCaffrey	NULL
,	NULL
J.L	NULL
.	NULL

Strominger	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1993	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
novel	NULL
cyclosporin-sensitive	NULL
element	NULL
in	NULL
the	NULL
human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
gene	NULL
promoter	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:1365-1379	NULL
.	NULL

20	NULL
.	NULL

Rooney	NULL
,	NULL
JW	NULL
.	NULL

,	NULL
M.R	NULL
.	NULL

Hodge	NULL
,	NULL
P.	NULL
McCaffrey	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
L.	NULL
Glimcher	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
common	NULL
factor	NULL
regulates	NULL
both	NULL
Th1-	NULL
and	NULL
Th2-specific	NULL
cytokine	NULL
gene	NULL
expression	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

13:625-633	NULL
.	NULL

21	NULL
.	NULL

Mattila	NULL
,	NULL
PS	NULL
.	NULL

,	NULL
K.S	NULL
.	NULL

Ullman	NULL
,	NULL
S.	NULL
Fiering	NULL
,	NULL
E.A	NULL
.	NULL

Emmel	NULL
,	NULL
M.	NULL
McCutcheon	NULL
,	NULL
G.R	NULL
.	NULL

Crabtree	NULL
,	NULL
and	NULL
L.A.	NULL
Herzenberg	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
actions	NULL
of	NULL
cyclosporin	NULL
A	NULL
and	NULL
FK-506	NULL
suggest	NULL
a	NULL
novel	NULL
step	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

94425-4433	NULL
.	NULL

22	NULL
.	NULL

Brabletz	NULL
,	NULL
T.	NULL
,	NULL
I.	NULL
Pietrowsky	NULL
,	NULL
and	NULL
E.	NULL
Serfling	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
immunosuppressive	NULL
FK-506	NULL
and	NULL
cyclosporin	NULL
A	NULL
inhibit	NULL
the	NULL
generation	NULL
of	NULL
protein	NULL
factors	NULL
binding	NULL
to	NULL
the	NULL
two	NULL
purine	NULL
boxes	NULL
of	NULL
the	NULL
interleukin	NULL
2	NULL
enhancer	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19:61-67	NULL
.	NULL

23	NULL
.	NULL

Banerji	NULL
,	NULL
$	NULL
.S	NULL
.	NULL

,	NULL
J.N	NULL
.	NULL

Parsons	NULL
,	NULL
and	NULL
M.J.	NULL
Tocci	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
im-munosuppressant	NULL
FK-506	NULL
specifically	NULL
inhibits	NULL
mitogen-induced	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
promoter	NULL
and	NULL
the	NULL
isolated	NULL
enhancer	NULL
elements	NULL
NFIL-Z2A	NULL
and	NULL
NF-AT1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:4074-4087	NULL
.	NULL

24	NULL
.	NULL

Szabo	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
J.S	NULL
.	NULL

Gold	NULL
,	NULL
T.L	NULL
.	NULL

Murphy	NULL
,	NULL
and	NULL
K.M	NULL
.	NULL

Murphy	NULL
.	NULL

1993	NULL
.	NULL

Identification	NULL
of	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
controlling	NULL
interleukin-4	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
:	NULL
roles	NULL
for	NULL
NFY	NULL
and	NULL
NF-ATe	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:4793-4805	NULL
.	NULL

25	NULL
.	NULL

Tokumitsu	NULL
,	NULL
H.	NULL
,	NULL
E.S	NULL
.	NULL

Masuda	NULL
,	NULL
K.1	NULL
.	NULL

Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1993	NULL
.	NULL

Purification	NULL
of	NULL
the	NULL
120	NULL
kDa	NULL
component	NULL
of	NULL
the	NULL
human	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NF-AT	NULL
)	NULL
:	NULL
reconstitution	NULL
of	NULL
binding	NULL
activity	NULL
to	NULL
the	NULL
cis-acting	NULL
element	NULL
of	NULL
the	NULL
GM-CSF	NULL
and	NULL
IL-2	NULL
promoter	NULL
with	NULL
AP-1	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

196:737-744	NULL
.	NULL

26	NULL
.	NULL

Venkataraman	NULL
,	NULL
L.	NULL
,	NULL
D.A	NULL
.	NULL

Francis	NULL
,	NULL
Z.	NULL
Wang	NULL
,	NULL
J.	NULL
Liu	NULL
,	NULL
TL	NULL
.	NULL

Roth-stein	NULL
,	NULL
and	NULL
R.	NULL
Sen.	NULL
1994	NULL
.	NULL

Cyclosporin-A	NULL
sensitive	NULL
induction	NULL
of	NULL
NF-AT	NULL
in	NULL
murine	NULL
B	NULL
cells	NULL
.	NULL

Immunity	NULL
.	NULL

1:189-196	NULL
.	NULL

27	NULL
.	NULL

Choi	NULL
,	NULL
M.S.K	NULL
.	NULL

,	NULL
R.D	NULL
.	NULL

Brines	NULL
,	NULL
M.J.	NULL
Holman	NULL
,	NULL
and	NULL
G.G.B	NULL
.	NULL

Klaus	NULL
.	NULL

1994	NULL
.	NULL

Induction	NULL
of	NULL
NF-AT	NULL
in	NULL
normal	NULL
B	NULL
lymphocytes	NULL
by	NULL
anti-immunoglobulin	NULL
or	NULL
CD40	NULL
ligand	NULL
in	NULL
conjunction	NULL
with	NULL
IL4	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

Immunity	NULL
.	NULL

1:179-187	NULL
.	NULL

Goldfeld	NULL
,	NULL
A.E	NULL
.	NULL

,	NULL
E.	NULL
Tsai	NULL
,	NULL
R.	NULL
Kincaid	NULL
,	NULL
P.J	NULL
.	NULL

Belshaw	NULL
,	NULL
S.L	NULL
.	NULL

Schrieber	NULL
,	NULL
J.L	NULL
.	NULL

Strominger	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1994	NULL
.	NULL

Calcineurin	NULL
mediates	NULL
human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
gene	NULL
induction	NULL
in	NULL
stimulated	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180:763-768	NULL
.	NULL

McCaffrey	NULL
,	NULL
PG	NULL
.	NULL

,	NULL
C.	NULL
Luo	NULL
,	NULL
TK	NULL
.	NULL

Kerppola	NULL
,	NULL
J.	NULL
Jain	NULL
,	NULL
T.M	NULL
.	NULL

Badalian	NULL
,	NULL
A.M.	NULL
Ho	NULL
,	NULL
E.	NULL
Burgeon	NULL
,	NULL
W.S	NULL
.	NULL

Lane	NULL
,	NULL
J.N	NULL
.	NULL

Lambert	NULL
,	NULL
T.	NULL
Curran	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
.	NULL

Isolation	NULL
of	NULL
the	NULL
cyclosporin-sensitive	NULL
T	NULL
cell	NULL
transcription	NULL
factor	NULL
NFATp	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

262:750-754	NULL
.	NULL

Northrop	NULL
,	NULL
J.P.	NULL
,	NULL
SN	NULL
.	NULL

Ho	NULL
,	NULL
L.	NULL
Chen	NULL
,	NULL
D.J	NULL
.	NULL

Thomas	NULL
,	NULL
L.A.	NULL
Tim-merman	NULL
,	NULL
G.P	NULL
.	NULL

Nolan	NULL
,	NULL
A.	NULL
Admon	NULL
,	NULL
and	NULL
G.R	NULL
.	NULL

Crabtree	NULL
.	NULL

1994	NULL
.	NULL

NF-AT	NULL
components	NULL
define	NULL
a	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
targeted	NULL
in	NULL
T-cell	NULL
activation	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

369:497-502	NULL
.	NULL

Perussia	NULL
,	NULL
B.	NULL
,	NULL
C.	NULL
Ramoni	NULL
,	NULL
I.	NULL
Anegon	NULL
,	NULL
M.C	NULL
.	NULL

Cuturi	NULL
,	NULL
J.	NULL
Faust	NULL
,	NULL
and	NULL
G.	NULL
Trinchieri	NULL
.	NULL

1987	NULL
.	NULL

Preferential	NULL
proliferation	NULL
of	NULL
natural	NULL
killer	NULL
cells	NULL
among	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
cocul-tured	NULL
with	NULL
B	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
.	NULL

Nat	NULL
.	NULL

Immun	NULL
.	NULL

Cell	NULL
Growth	NULL
Regul	NULL
.	NULL

6:171-188	NULL
.	NULL

McCaffrey	NULL
,	NULL
PG	NULL
.	NULL

,	NULL
J.	NULL
Jain	NULL
,	NULL
C.	NULL
Jamieson	NULL
,	NULL
R.	NULL
Sen	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
T	NULL
cell	NULL
nuclear	NULL
factor	NULL
resembling	NULL
NF-AT	NULL
binds	NULL
to	NULL
an	NULL
NF-kB	NULL
site	NULL
and	NULL
to	NULL
the	NULL
conserved	NULL
lymphokine	NULL
promoter	NULL
sequence	NULL
``	NULL
cytokine-1	NULL
.	NULL
``	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:1864-1871	NULL
.	NULL

Dignam	NULL
,	NULL
J.D	NULL
.	NULL

,	NULL
R.M	NULL
.	NULL

Lebovitz	NULL
,	NULL
and	NULL
R.G	NULL
.	NULL

Roeder	NULL
.	NULL

1983	NULL
.	NULL

Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11:1475-1489	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
Z	NULL
.	NULL

Miner	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1993	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
preexisting	NULL
and	NULL
nuclear	NULL
forms	NULL
of	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151:837-848	NULL
.	NULL

Ho	NULL
,	NULL
A.M.	NULL
,	NULL
J.	NULL
Jain	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
PG	NULL
.	NULL

Hogan	NULL
.	NULL

1994	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NFATp	NULL
in	NULL
a	NULL
neuronal	NULL
cell	NULL
line	NULL
and	NULL
in	NULL
the	NULL
murine	NULL
nervous	NULL
system	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:28181-28186	NULL
.	NULL

McCaffrey	NULL
,	NULL
PG	NULL
.	NULL

,	NULL
A.E	NULL
.	NULL

Goldfeld	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
role	NULL
of	NULL
NFATp	NULL
in	NULL
cyclosporin	NULL
A-sensitive	NULL
tumor	NULL
necrosis	NULL
factor-gene	NULL
transcription	NULL
.	NULL

J.	NULL
Biol	NULL
Chem	NULL
.	NULL

269:30445-30450	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
P.G	NULL
.	NULL

McCaffrey	NULL
,	NULL
V.E	NULL
.	NULL

Valge-Archer	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1992	NULL
.	NULL

Nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
contains	NULL
Fos	NULL
and	NULL
Jun	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

356:801-804	NULL
.	NULL

Ravetch	NULL
,	NULL
J	NULL
V.	NULL
,	NULL
and	NULL
J.-P.	NULL
Kinet	NULL
.	NULL

1991	NULL
.	NULL

Fc	NULL
Receptors	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

9:457-492	NULL
.	NULL

Wirthmueller	NULL
,	NULL
U.	NULL
,	NULL
T.	NULL
Kurosaki	NULL
,	NULL
M.S	NULL
.	NULL

Murakami	NULL
,	NULL
and	NULL
JV	NULL
.	NULL

Ravetch	NULL
.	NULL

1992	NULL
.	NULL

Signal	NULL
transduction	NULL
by	NULL
FeyRIII	NULL
(	NULL
CD16	NULL
)	NULL
is	NULL
mediated	NULL
through	NULL
the	NULL
y	NULL
chain	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175:1381-1390	NULL
.	NULL

Todd	NULL
,	NULL
M.D	NULL
.	NULL

,	NULL
M.J.	NULL
Grusby	NULL
,	NULL
J.A	NULL
.	NULL

Lederer	NULL
,	NULL
E.	NULL
Lacy	NULL
,	NULL
A.H.	NULL
Lichtman	NULL
,	NULL
and	NULL
L.H	NULL
.	NULL

Glimcher	NULL
.	NULL

1993	NULL
.	NULL

Transcription	NULL
of	NULL
the	NULL
interleukin	NULL
4	NULL
gene	NULL
is	NULL
regulated	NULL
by	NULL
multiple	NULL
promotor	NULL
elements	NULL
.	NULL

810	NULL
NFAT	NULL
Activation	NULL
in	NULL
NK	NULL
Cells	NULL
41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

177:1663-1674	NULL
.	NULL

Goldfeld	NULL
,	NULL
A.E	NULL
.	NULL

,	NULL
EK	NULL
.	NULL

Flemington	NULL
,	NULL
V.A	NULL
.	NULL

Boussiotis	NULL
,	NULL
C.M	NULL
.	NULL

Theodos	NULL
,	NULL
R.G	NULL
.	NULL

Titus	NULL
,	NULL
J.L	NULL
.	NULL

Strominger	NULL
,	NULL
and	NULL
S.H	NULL
.	NULL

Speck	NULL
.	NULL

1992	NULL
.	NULL

Transcription	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
gene	NULL
is	NULL
rapidly	NULL
induced	NULL
by	NULL
anti-immunoglobulin	NULL
and	NULL
blocked	NULL
by	NULL
cyclosporin	NULL
A	NULL
and	NULL
FK506	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

89:12198-12201	NULL
.	NULL

Yaseen	NULL
,	NULL
N.R	NULL
.	NULL

,	NULL
A.L	NULL
.	NULL

Maizel	NULL
,	NULL
F.	NULL
Wang	NULL
,	NULL
and	NULL
S.	NULL
Sharma	NULL
.	NULL

1993	NULL
.	NULL

Comparative	NULL
analysis	NULL
of	NULL
NFAT	NULL
(	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
)	NULL
complex	NULL
in	NULL
human	NULL
T	NULL
and	NULL
B	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:14285-14293	NULL
.	NULL

Chen	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
EV	NULL
.	NULL

Rothenberg	NULL
.	NULL

1994	NULL
.	NULL

Interleukin	NULL
2	NULL
transcription	NULL
factors	NULL
as	NULL
molecular	NULL
targets	NULL
for	NULL
cAMP	NULL
inhibition	NULL
:	NULL
delayed	NULL
inhibition	NULL
kinetics	NULL
and	NULL
combinatorial	NULL
transcription	NULL
roles	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

179:931-942	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
V.E	NULL
.	NULL

Valge-Archer	NULL
,	NULL
A.J	NULL
.	NULL

Sinskey	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
AP-1	NULL
site	NULL
at	NULL
-150	NULL
bp	NULL
,	NULL
but	NULL
not	NULL
the	NULL
NF-KB	NULL
site	NULL
,	NULL
is	NULL
likely	NULL
to	NULL
represent	NULL
the	NULL
major	NULL
target	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
in	NULL
the	NULL
interleukin	NULL
2	NULL
promoter	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175:853-862	NULL
.	NULL

Northrop	NULL
,	NULL
J.P.	NULL
,	NULL
K.S	NULL
.	NULL

Ullman	NULL
,	NULL
and	NULL
G.R	NULL
.	NULL

Crabtree	NULL
.	NULL

1993	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
components	NULL
of	NULL
the	NULL
lymphoid-specific	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NF-AT	NULL
)	NULL
complex	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:2917-2923	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
EA	NULL
.	NULL

Nalefski	NULL
,	NULL
PG	NULL
.	NULL

McCaffrey	NULL
,	NULL
RS	NULL
.	NULL

Johnson	NULL
,	NULL
B.M	NULL
.	NULL

Spiegelmen	NULL
,	NULL
V.	NULL
Papaioannou	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1994	NULL
.	NULL

Normal	NULL
peripheral	NULL
T-cell	NULL
function	NULL
in	NULL
c-fos	NULL
deficient	NULL
mice	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:1566-1574	NULL
.	NULL

Masuda	NULL
,	NULL
E.S	NULL
.	NULL

,	NULL
Y.	NULL
Naito	NULL
,	NULL
H.	NULL
Tokumitsu	NULL
,	NULL
D.	NULL
Campbell	NULL
,	NULL
F.	NULL
Saito	NULL
,	NULL
C.	NULL
Hannum	NULL
,	NULL
K.-I	NULL
.	NULL

Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1995	NULL
.	NULL

NFATx	NULL
,	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
family	NULL
that	NULL
is	NULL
expressed	NULL
predominantly	NULL
in	NULL
the	NULL
thymus	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:2697-2706	NULL
.	NULL

Aramburu	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
A.	NULL
Balboa	NULL
,	NULL
A.	NULL
Rodriguez	NULL
,	NULL
I.	NULL
Melero	NULL
,	NULL
M.	NULL
Alonso	NULL
,	NULL
J.L	NULL
.	NULL

Alonso	NULL
,	NULL
and	NULL
M.	NULL
Lopez-Botet	NULL
.	NULL

1993	NULL
.	NULL

Stimulation	NULL
of	NULL
IL2-activated	NULL
natural	NULL
killer	NULL
cells	NULL
through	NULL
the	NULL
Kp43	NULL
antigen	NULL
upregulates	NULL
TNFa	NULL
production	NULL
involving	NULL
the	NULL
LFA-1	NULL
integrin	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151:3420-3429	NULL
.	NULL

Windebank	NULL
,	NULL
K.P	NULL
.	NULL

,	NULL
RT	NULL
.	NULL

Abraham	NULL
,	NULL
G.	NULL
Powis	NULL
,	NULL
R.A.	NULL
Olsen	NULL
,	NULL
T.J.	NULL
Barna	NULL
,	NULL
and	NULL
P.J	NULL
.	NULL

Leibson	NULL
.	NULL

1988	NULL
.	NULL

Signal	NULL
transduction	NULL
during	NULL
human	NULL
natural	NULL
killer	NULL
cell	NULL
cell	NULL
activation	NULL
:	NULL
inositol	NULL
phosphate	NULL
generation	NULL
and	NULL
regulation	NULL
by	NULL
cyclic	NULL
AMP	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

141:3951-3957	NULL
.	NULL

Chong	NULL
,	NULL
A.S.F	NULL
.	NULL

,	NULL
P.	NULL
Scuderi	NULL
,	NULL
W.J	NULL
.	NULL

Grimes	NULL
,	NULL
and	NULL
E.M.	NULL
Mersch	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
targets	NULL
stimulate	NULL
IL-2	NULL
activated	NULL
killer	NULL
cells	NULL
to	NULL
produce	NULL
interferon	NULL
y	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

142:2133-2139	NULL
.	NULL

